Organic electroluminescent materials and devices

The described OLED architecture with sterically bulky groups addresses exciplex formation and reactive site issues, enhancing color saturation and efficiency while extending device lifetime.

JP2024167076APending Publication Date: 2024-11-29UNIVERSAL DISPLAY CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024080690
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-05-02
Filing Date
2024-05-17
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

Existing OLEDs face challenges in achieving saturated colors and efficient performance due to issues like exciplex formation and reactive sites, which affect device lifetime and efficiency.

Method used

Incorporating a specific organic light-emitting device architecture with a light-emitting layer comprising a first compound and a second compound, where the second compound has a LUMO energy of -2.33eV or less, and using sterically bulky groups to protect reactive sites, such as pyridine, to reduce exciplex formation and enhance device stability.

Benefits of technology

The solution results in OLEDs with improved color saturation, increased efficiency, and extended device lifetime by minimizing exciplex formation and reducing interactions between boron-containing hosts and emitters.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024167076000001_ABST
    Figure 2024167076000001_ABST
Patent Text Reader

Abstract

To provide an organic light emitting device (OLED) having an anode, a cathode, and an emissive layer disposed between the anode and the cathode.SOLUTION: In an organic light emitting device (OLED), an emissive layer contains a first compound of Formula I, and a second compound represented by a specific formula. In the OLED, the LUMO energy of the second compound is less than or equal to -2.33 eV, and at least one RD substituent is not hydrogen.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 63 / 503,367, filed May 19, 2023, and U.S. Provisional Application No. 63 / 519,322, filed August 14, 2023, the entire contents of both applications being incorporated herein by reference.

[0002] This disclosure relates generally to novel device architectures and OLED devices having these novel architectures, and their uses. [Background technology]

[0003] Optoelectronic devices that utilize organic materials are becoming increasingly desirable for a variety of reasons. Many of the materials used to make such devices are relatively inexpensive, so organic optoelectronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as flexibility, may make them well suited for certain applications, such as fabrication on flexible substrates. Examples of organic optoelectronic devices include organic light-emitting diodes / devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, organic materials may have performance advantages over traditional materials.

[0004] OLEDs utilize thin organic films that emit light when a voltage is applied across the device and are becoming an increasingly interesting technology for use in applications such as flat panel displays, lighting, and backlighting.

[0005] One application of phosphorescent molecules is full color displays. Industry standards for such displays require pixels adapted to emit specific colors, referred to as "saturated" colors. In particular, these standards require saturated red, green, and blue pixels. Alternatively, OLEDs can be designed to emit white light. Conventional liquid crystal display emission from a white backlight is filtered with absorbing filters to produce red, green, and blue emission. Similar techniques can be used with OLEDs. White OLEDs can be either single-emissive-layer (EML) devices or stack structures. Color can be measured using CIE coordinates, which are well known in the art.

[0006] overview An organic light emitting device (OLED) is provided that includes an anode; a cathode; and an emissive layer disposed between the anode and the cathode. The emissive layer includes a first compound and a second compound. The first compound has the structure of Formula I: [ka] and the second compound has the structure of Formula II [ka] In Formula I and Formula II, each of moieties A, B, C and D is independently a monocyclic ring or a polycyclic fused ring system, and each ring of the monocyclic ring or polycyclic fused ring system is independently a 5- or 6-membered, carbocyclic or heterocyclic ring; X 1 ~X 5 each is independently C or N; K 1 , K 2 and K 3 Each of R α ), P(R α ), B(R α ), C(R α )(R β ) and Si(R α )(R β) selected from the group consisting of; m and n are each independently 0 or 1; and m+n=1 or 2; Z 1 ~Z 11 each is independently C or N; x and y are each independently 0 or 1; wherein the LUMO energy of the second compound is less than or equal to −2.33 eV; L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 each is independently a direct bond or a linker selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; R A , R B , R C , R D , R E , R F , and R G each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; R α , R β , R, R', R'', R''', R A , R B , R C , R D , R E , R F , and R Geach is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; Any two substituents may be joined or fused to form a ring; At least one R D The substituents are not hydrogen; and Moiety A is benzimidazole, moieties B and C are each phenyl, moiety D is pyridine, and X 1 If is N, then at least one of the following two conditions is true: (1) At least one R that is not hydrogen D The total molecular weight of all of the substituents is ≥ 57 g / mol; or (2) Two R’s D The substituents are joined together to form a ring.

[0007] Also provided are consumer products that include the OLEDs described herein. [Brief description of the drawings]

[0008] [Figure 1] FIG. 1 shows an organic light emitting device.

[0009] [Diagram 2] FIG. 2 shows an inverted organic light emitting device that does not have a separate electron transport layer.

[0010] [Diagram 3] FIG. 3 shows a graph of modeled P-polarized photoluminescence as a function of angle for emitters having different vertical dipole ratio (VDR) values.

[0011] [Figure 4] 4a, 4b and 4c show the calculated intermolecular contacts between the boron atom of the host and the center of the pyridine ring of the Pt complex. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0012] A. Terminology Unless otherwise stated, the following terms used herein are defined as follows.

[0013] As used herein, the term "organic" includes polymeric and small molecule organic materials that can be used to fabricate organic optoelectronic devices. "Small molecule" refers to any organic material that is not a polymer, and "small molecules" may in fact be quite large. Small molecules may contain repeat units in some circumstances. For example, the use of long chain alkyl groups as a substituent does not remove a molecule from the "small molecule" class. Small molecules may be incorporated into polymers, for example, as pendant groups on a polymer backbone or as part of the backbone. Small molecules can also serve as the core moiety of dendrimers, which consist of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. Dendrimers may be "small molecules," and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.

[0014] As used herein, "top" means furthest from the substrate, while "bottom" means closest to the substrate. When a first layer is described as "disposed over" a second layer, the first layer is disposed further from the substrate. There may be other layers between the first and second layers, unless it is specified that the first layer is "in contact with" the second layer. For example, a cathode may be described as "disposed over" an anode, even though there may be various organic layers in between.

[0015] As used herein, "solution processable" means capable of being dissolved, dispersed or transported in and / or deposited from a liquid medium, either in the form of a solution or suspension.

[0016] A ligand may be referred to as "photoactive" if it is believed that the ligand directly contributes to the photoactive properties of the emissive material. A ligand may be referred to as "ancillary" if it is believed that the ligand does not contribute to the photoactive properties of the emissive material, although the ancillary ligand may modify the properties of the photoactive ligand.

[0017] As used herein and generally understood by those skilled in the art, a first "highest occupied molecular orbital" (HOMO) or "lowest unoccupied molecular orbital" (LUMO) energy level is "greater than" or "higher than" a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IPs) are measured as negative energies relative to the vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (a less negative IP). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (a less negative EA). In a conventional energy level diagram with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A "higher" HOMO or LUMO energy level appears closer to the top of such a diagram than a "lower" HOMO or LUMO energy level.

[0018] As used herein, and generally understood by those skilled in the art, a first work function is "greater than" or "higher than" a second work function if the first work function has a higher absolute value. Since work functions are generally measured as negative numbers relative to the vacuum level, this means that a "higher" work function is more negative. In a conventional energy level diagram, with the vacuum level at the top, a "higher" work function is illustrated as being further away from the vacuum level in a downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.

[0019] The terms "halo," "halogen," and "halide" are used interchangeably and refer to fluorine, chlorine, bromine, and iodine.

[0020] The term "acyl" refers to a substituted carbonyl group (C(O)-R s )

[0021] The term "ester" refers to a substituted oxycarbonyl (-OC(O)-R s Or -C(O)-OR s ) group.

[0022] The term "ether" means -OR s Refers to the base.

[0023] The terms "sulfanyl" and "thioether" are used interchangeably, and include -SR s Refers to the base.

[0024] The term "selenyl" means -SeR s Refers to the base.

[0025] The term "sulfinyl" refers to -S(O)-R s Refers to the base.

[0026] The term "sulfonyl" means -SO2-R s Refers to the base.

[0027] The term "phosphino" refers to -P(R s ) groups, where each R s may be the same or different.

[0028] The term "silyl" means -Si(R s ) groups, where each R s may be the same or different.

[0029] The term "germyl" means -Ge(R s ) groups, where each R s may be the same or different.

[0030] The term "boryl" means -B(R s )2 groups or their Lewis adducts -B(R s ) groups, where R s may be the same or different.

[0031] In each of the above, R s may be hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, and combinations thereof. s is selected from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.

[0032] The term "alkyl" refers to and includes both straight and branched chain alkyl groups. Preferred alkyl groups have 1 to 15 carbon atoms and include methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and the like. Additionally, the alkyl groups may be optionally substituted.

[0033] The term "cycloalkyl" refers to and includes monocyclic, polycyclic, and spiroalkyl groups. Preferred cycloalkyl groups are those containing from 3 to 12 ring carbon atoms, including cyclopropyl, cyclopentyl, cyclohexyl, bicyclo[3.1.1]heptyl, spiro[4.5]decyl, spiro[5.5]undecyl, adamantyl, and the like. Additionally, the cycloalkyl groups may be optionally substituted.

[0034] The term "heteroalkyl" or "heterocycloalkyl" refers to an alkyl or cycloalkyl group, respectively, having at least one carbon atom replaced by a heteroatom. Optionally, at least one heteroatom is selected from O, S, N, P, B, Si, and Se, preferably O, S, or N. Furthermore, said heteroalkyl group or said heterocycloalkyl group may be optionally substituted.

[0035] The term "alkenyl" refers to and includes both straight-chain and branched-chain alkene groups. An alkenyl group is essentially an alkyl group containing at least one carbon-carbon double bond in the alkyl chain. A cycloalkenyl group is essentially a cycloalkyl group containing at least one carbon-carbon double bond in the cycloalkyl ring. As used herein, the term "heteroalkenyl" refers to an alkenyl group having at least one carbon atom replaced by a heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, Si, and Se, preferably O, S, or N. Preferred alkenyl, cycloalkenyl, or heteroalkenyl groups are those containing 2 to 15 carbon atoms. Furthermore, the alkenyl, cycloalkenyl, or heteroalkenyl groups may be optionally substituted.

[0036] The term "alkynyl" refers to and includes both straight and branched chain alkyne groups. An alkynyl group is essentially an alkyl group that contains at least one carbon-carbon triple bond in the alkyl chain. Preferred alkynyl groups are those that contain 2 to 15 carbon atoms. Additionally, said alkynyl groups may be optionally substituted.

[0037] The terms "aralkyl" and "arylalkyl" are used interchangeably and refer to an alkyl group substituted with an aryl group, which may be optionally substituted.

[0038] The term "heterocyclic group" refers to and includes aromatic and non-aromatic cyclic groups containing at least one heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, Si, and Se, preferably O, S, or N. Heteroaromatic cyclic groups may be used interchangeably with heteroaryl. Preferred hetero non-aromatic cyclic groups are those having 3-7 ring atoms, containing at least one heteroatom, and including cyclic amines such as morpholino, piperidino, pyrrolidino, and cyclic ethers / thioethers such as tetrahydrofuran, tetrahydropyran, and tetrahydrothiophene. Furthermore, the heterocyclic groups may be optionally substituted.

[0039] The term "aryl" refers to and includes both monocyclic aromatic hydrocarbyl groups and polycyclic aromatic ring systems. Polycyclic rings can have two or more rings with two carbons shared between two adjacent rings (the rings being "fused"), where at least one of the rings is an aromatic hydrocarbon group, for example, the other rings can be cycloalkyl, cycloalkenyl, aryl, heterocyclic, and / or heteroaryl. Preferred aryl groups are those containing 6 to 30 carbon atoms, preferably 6 to 20 carbon atoms, more preferably 6 to 12 carbon atoms. Particularly preferred are aryl groups having 6 carbons, 10 carbons, or 12 carbons. Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, with phenyl, biphenyl, triphenylene, triphenylene, fluorene, and naphthalene being preferred. Furthermore, the aryl group may be optionally substituted.

[0040] The term "heteroaryl" refers to and includes both monocyclic aromatic groups and polycyclic aromatic ring systems containing at least one heteroatom. Heteroatoms include, but are not limited to, O, S, N, P, B, Si, and Se. In many instances, O, S, or N are the preferred heteroatoms. Heteromonocyclic aromatic systems are preferably monocyclic rings having 5 or 6 ring atoms, and the rings can have 1 to 6 heteroatoms. Heteropolycyclic ring systems can have two or more rings in which two atoms are common to two adjacent rings (the rings are "fused"), and at least one of the rings is heteroaryl, and the other rings can be, for example, cycloalkyl, cycloalkenyl, aryl, heterocyclic, and / or heteroaryl. Heteropolycyclic aromatic ring systems can have 1 to 6 heteroatoms per ring of the polycyclic aromatic ring system. Preferred heteroaryl groups are those containing 3 to 30 carbon atoms, preferably 3 to 20 carbon atoms, and more preferably 3 to 12 carbon atoms.Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, Examples of heteroaryl groups include azoles, quinolines, isoquinolines, cinnolines, quinazolines, quinoxalines, naphthyridines, phthalazines, pteridines, xanthenes, acridines, phenazines, phenothiazines, phenoxazines, benzofuropyridines, furodipyridines, benzothienopyridines, thienodipyridines, benzoselenophenopyridines, and selenophenodipyridines, and preferably dibenzothiophenes, dibenzofurans, dibenzoselenophenes, carbazoles, indolocarbazoles, imidazoles, pyridines, triazines, benzimidazoles, 1,2-azaborines, 1,3-azaborines, 1,4-azaborines, borazines, and aza analogs thereof. Furthermore, the heteroaryl groups may be optionally substituted.

[0041] Of the aryl and heteroaryl groups listed above, triphenylene, naphthalene, anthracene, dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, pyrazine, pyrimidine, triazine, and benzimidazole groups, and their respective aza analogues, are of particular interest.

[0042] As used herein, the terms alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aralkyl, heterocyclic, aryl, and heteroaryl are independently unsubstituted or independently substituted with one or more common substituents.

[0043] In many instances, the typical substituents are selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, selenyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

[0044] In some instances, preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.

[0045] In some instances, more preferred common substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, sulfanyl, and combinations thereof.

[0046] In yet other instances, the most preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.

[0047] The terms "substituted" and "substituted" refer to a substituent other than H attached to the relevant position (e.g., carbon or nitrogen). For example, R 1If represents a single substitution, one R 1 must be other than H (i.e., a substitution). Similarly, R 1 If represents a disubstitution, R 1 must be other than H. Similarly, R 1 When R represents zero or no substitution, 1 can be hydrogen at an available valence of a ring atom, as in the case of carbon atoms in benzene and nitrogen atoms in pyrrole, or simply represents nothing in the case of ring atoms with fully filled valences (e.g., nitrogen in pyridine). The maximum number of substitutions possible in a ring structure depends on the total number of available valences on the ring atoms.

[0048] As used herein, "combinations thereof" refers to one or more members of the applicable list being combined to form a known or chemically stable configuration that one of skill in the art can conceive from the applicable list. For example, alkyl and deuterium can be combined to form a partially or fully deuterated alkyl group; halogen and alkyl can be combined to form a halogenated alkyl substituent; and halogen, alkyl, and aryl can be combined to form a halogenated aryl alkyl. In one example, the term substituted includes combinations of 2-4 of the listed groups. In another example, the term substituted includes combinations of 2-3 groups. In yet another example, the term substituted includes combinations of 2 groups. Preferred combinations of substituents include those that contain up to 50 atoms that are not hydrogen or deuterium, or those that contain up to 40 atoms that are not hydrogen or deuterium, or those that contain up to 30 atoms that are not hydrogen or deuterium. In many examples, preferred combinations of substituents include up to 20 atoms that are not hydrogen or deuterium.

[0049] The designation "aza" in the fragments described herein, such as aza-dibenzofuran, aza-dibenzothiophene, etc., means that one or more of the CH groups in each aromatic ring can be replaced by a nitrogen atom, for example, but not by way of limitation, azatriphenylene includes both dibenzo[f,h]quinoxaline and dibenzo[f,h]quinoline. One of skill in the art can easily imagine other nitrogen analogs of the above-mentioned aza derivatives, and all such analogs are intended to be encompassed by the terms described herein.

[0050] As used herein, "deuterium" refers to an isotope of hydrogen. Deuterated compounds can be readily prepared using methods known in the art. For example, U.S. Pat. No. 8,557,400, International Publication No. WO 2006 / 095951, and U.S. Patent Application Publication No. 2011 / 0037057, the contents of which are incorporated by reference in their entirety, describe the preparation of deuterium-substituted organometallic complexes. Further reference is made to Tetrahedron 2015, 71, 1425-30 (Ming Yan et al.) and Angew. Chem. Int. Ed. (Reviews) 2007, 46, 7744-65 (Atzrodt et al.), the contents of which are incorporated by reference in their entirety, which describe efficient routes for the deuteration of methylene hydrogens in benzylamines and the replacement of aromatic ring hydrogens with deuterium, respectively.

[0051] It is understood that when a molecular fragment is described as being a substituent or attached to another moiety, the name may be described as being the fragment (e.g., phenyl, phenylene, naphthyl, dibenzofuryl) or the entire molecule (e.g., benzene, naphthalene, dibenzofuran). As used herein, different designations of substituents or attached fragments are considered equivalent.

[0052] In some cases, the adjacent substituents of a pair can be optionally bonded or fused to form a ring. Preferred rings are 5-, 6-, or 7-membered carbocyclic or heterocyclic rings, including both cases where the portion of the ring formed by the pair of substituents is saturated and cases where the portion of the ring formed by the pair of substituents is unsaturated. As used herein, "adjacent" means that the two related substituents can be adjacent to each other on the same ring, or can be adjacent to each other on the two rings that have the two nearest available substitutable positions, such as 2- and 2'-positions in biphenyl, or 1- and 8-positions in naphthalene, as long as they can form a stable fused ring system.

[0053] Layers, materials, regions, and devices may be described herein in relation to the color of light they emit. Generally, as used herein, a light-emitting region described as producing a particular color of light can include one or more light-emitting layers arranged relative to one another in a stack.

[0054] As used herein, a "red" layer, material, region, or device refers to one that emits light or has an emission spectrum with a peak wavelength in the range of about 580 nm to 700 nm. Similarly, a "green" layer, material, region, or device refers to one that emits light or has an emission spectrum with a peak wavelength in the range of about 500 nm to 600 nm. A "blue" layer, material, region, or device refers to one that emits light or has an emission spectrum with a peak wavelength in the range of about 400 nm to 500 nm. A "yellow" layer, material, region, or device refers to one that has an emission spectrum with a peak wavelength in the range of about 540 nm to 600 nm. In some arrangements, separate regions, layers, materials, regions, or devices can provide separate "dark blue" and "light blue" lights. As used herein, in an arrangement that provides separate "light blue" and "dark blue", the "dark blue" component refers to one that has a peak emission wavelength that is at least about 4 nm less than the peak emission wavelength of the "light blue" component. Typically, a "light blue" component has a peak emission wavelength in the range of about 465 nm to 500 nm, and a "dark blue" component has a peak emission wavelength in the range of about 400 nm to 470 nm, although these ranges may vary for some configurations. Similarly, a color changing layer refers to a layer that converts or modifies light of another color into light having a wavelength specific to that color. For example, a "red" color filter refers to a filter that results in light having a wavelength in the range of about 580 nm to 700 nm. Generally, there are two classes of color changing layers: color filters that remove unwanted wavelengths of light to modify the spectrum, and color changing layers that convert high energy photons to low energy. A "color" component refers to a component that, when activated or used, produces or emits light having a specific color, as described above. For example, a "first light-emitting region of a first color" and a "second light-emitting region of a second color different from said first color" describe two light-emitting regions that, when activated in a device, emit two different colors, as described above.

[0055] As used herein, light-emitting materials, layers, and regions can be distinguished from each other and from other structures based on the light that is initially generated by the material, layer, or region, as opposed to the light that is ultimately emitted by the same or a different structure. Typically, the initial generation of light is the result of a change in energy level that results in the emission of a photon. For example, an organic light-emitting material may initially generate blue light, which may be converted to red or green light by color filters, quantum dots, or other structures, such that the complete light-emitting stack or subpixel emits red or green light. In this case, the initial light-emitting material or layer may be referred to as the "blue" component, even if the subpixel is the "red" or "green" component.

[0056] In some instances, it may be preferable to describe the color of components of light-emitting regions, subpixels, color-changing layers, etc., in 1931 CIE coordinates. For example, a yellow light-emitting material may have multiple peak emission wavelengths, one within or near the edge of the "green" region as described above, and another within or near the edge of the "red" region. Thus, as used herein, each color term also corresponds to a shape in the 1931 CIE coordinate color space. The shape of the 1931 CIE color space is constructed by tracing the coordinates between two color points and any additional internal points. For example, the internal shape parameters for red, green, blue, and yellow may be defined as follows: [Table 1]

[0057] Further details regarding OLEDs and the above definitions can be found in US Pat. No. 7,279,704, which is incorporated by reference in its entirety.

[0058] As disclosed herein, light-emitting layers or materials, such as light-emitting layer 135 and light-emitting layer 220 shown in Figures 1-2, respectively, can include quantum dots. An "emissive layer" or "light-emitting material" as disclosed herein can include organic light-emitting materials and / or light-emitting materials that include quantum dots or equivalent structures, unless otherwise indicated explicitly or by context as understood by one of ordinary skill in the art. Generally, light-emitting layers include light-emitting materials within a host matrix. Such light-emitting layers can include only quantum dot materials that convert light emitted by separate light-emitting materials or other light emitters, or can also include separate light-emitting materials or other light emitters, or can emit light themselves directly from the application of electrical current. Similarly, color-changing layers, color filters, up-conversion, or down-conversion layers or structures can include materials that include quantum dots, but such layers are not considered "light-emitting layers" as disclosed herein. In general, an "emissive layer" or material is one that emits initial light based on injected charges, which may be modified by another layer, such as a color filter or other color changing layer, that does not itself emit initial light within the device, but can re-emit altered light of different spectral content based on absorption of the initial light emitted by the emissive layer and down-conversion to a lower energy emission. In some embodiments disclosed herein, the color changing layer, color filter, up-conversion, and / or down-conversion layer may be located external to the OLED device, such as above or below an electrode of the OLED device.

[0059] Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For organic layers, preferred methods include deposition by thermal evaporation, such as those described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entirety, inkjet, organic vapor phase deposition (OVPD), such as those described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and organic vapor jet printing (OVJP, also referred to as organic vapor jet deposition (OVJD)), such as those described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution-based processes. Solution-based processes are preferably carried out in a nitrogen or inert atmosphere. For other layers, preferred methods include thermal evaporation. Preferred patterning methods include patterning associated with some of the deposition methods such as deposition through masks, cold welding, such as those described in U.S. Patent Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entirety, and inkjet and OVJD. Other methods may be used. The material to be deposited may be modified to be compatible with the particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents with 20 or more carbons may be used, with 3-20 carbons being a preferred range. Materials with asymmetric structures may have better solution processability than those with symmetric structures, as asymmetric materials may be less prone to recrystallization. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.

[0060] Devices fabricated according to embodiments of the present disclosure may further include a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment, including moisture, vapors and / or gases, etc. The barrier layer may be deposited on, under or next to the substrate, the electrodes, or on any other portion of the device, including the edges. The barrier layer may include a single layer or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase and compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate inorganic or organic compounds or both. Preferred barrier layers include mixtures of polymeric and non-polymeric materials, as described in U.S. Pat. No. 7,968,146, PCT Patent Application Nos. PCT / US2007 / 023098 and PCT / US2009 / 042829, which are incorporated herein by reference in their entireties. To be considered a "mixture", the polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and / or simultaneously. The weight ratio of polymeric to non-polymeric materials can be in the range of 95:5 to 5:95. The polymeric and non-polymeric materials can be made from the same precursor materials. In one example, the mixture of polymeric and non-polymeric materials consists essentially of polymeric silicon and inorganic silicon.

[0061] It is believed that the internal quantum efficiency (IQE) of fluorescent OLEDs can exceed the 25% spin statistical limit due to delayed fluorescence. As used herein, there are two types of delayed fluorescence: P-type delayed fluorescence and E-type delayed fluorescence. P-type delayed fluorescence arises from triplet-triplet annihilation (TTA).

[0062] On the other hand, E-type delayed fluorescence does not depend on the collision of two triplets, but rather on the thermal population between the triplet state and the singlet excited state. Compounds capable of generating E-type delayed fluorescence are required to have a very small singlet-triplet gap. Thermal energy can activate the transition from the triplet state back to the singlet state. This type of delayed fluorescence is also known as thermally activated delayed fluorescence (TADF). A unique feature of TADF is that the delayed component increases with increasing temperature due to increased thermal energy. If the reverse intersystem crossing rate is fast enough to minimize the non-radiative decay from the triplet state, the fraction of the reversely assembled singlet excited state can potentially reach 75%. The total singlet fraction can be 100%, far exceeding the spin statistical limit of electrically generated excitons.

[0063] E-type delayed fluorescence properties can be found in exciplex systems or single compounds. Without being bound by theory, it is believed that E-type delayed fluorescence requires that the emitting material has a small singlet-triplet energy gap (ΔE-T). Organic, non-metal-containing, donor-acceptor emitting materials may be able to achieve this. Emission in these materials is often characterized as donor-acceptor charge transfer (CT) type emission. The spatial separation of the HOMO and LUMO in these donor-acceptor type compounds often results in a small ΔE-T. These states may include CT states. In many cases, donor-acceptor emitting materials are constructed by linking an electron donor moiety, such as an amino- or carbazole derivative, with an electron acceptor moiety, such as an N-containing six-membered aromatic ring.

[0064] Devices made according to embodiments of the present disclosure can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into various electrical products or intermediate components. Examples of such electrical products or intermediate components include display screens, lighting devices (such as discrete light source devices or lighting panels) that can be utilized by end-user product manufacturers. Such electronic component modules can optionally include driving electronics and / or power sources. Devices made according to embodiments of the present disclosure can be incorporated into a wide variety of consumer products having one or more electronic component modules (or units) incorporated therein. Disclosed are consumer products that include OLEDs that include compounds of the present disclosure in the organic layer of the OLED. Such consumer products include any type of product that includes one or more light sources and / or one or more visual displays of some kind. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, lights for indoor or outdoor illumination and / or signaling, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, mobile phones, tablets, phablets, personal digital assistants (PDAs), wearable devices, laptop computers, digital cameras, camcorders, viewfinders, microdisplays (displays less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls including multiple displays aligned together, theater or stadium screens, and signage. A variety of control mechanisms can be used to control devices made according to the present disclosure, including passive matrix and active matrix. Many of the devices are intended for use within a temperature range that is comfortable for humans, such as 18°C ​​to 30°C, and more preferably room temperature (20-25°C), but may also be used outside this temperature range, for example, at temperatures between -40°C and +80°C Celsius.

[0065] The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may use the materials and structures. More generally, organic devices such as organic transistors may use the materials and structures.

[0066] In common parlance in the art, a "subpixel" can refer to a light-emitting area, which can be a single layer EML, a stacked device, or the like, in combination with any color changing layers used to modify the color emitted by the light-emitting area.

[0067] As used herein, the "emissive region" of a subpixel refers to any and all light-emitting layers, regions, and devices that are primarily used to generate light for the subpixel. A subpixel may also include additional layers disposed in a stack with the emissive region that affect the color ultimately generated by the subpixel, such as color-changing layers as disclosed herein, although such color-changing layers are typically not considered "emissive layers" as disclosed herein. An unfiltered subpixel excludes color-changing components such as color-changing layers, but may include one or more emissive regions, layers, or devices.

[0068] In some configurations, a "light-emitting region" may include light-emitting materials that emit multiple colors of light. For example, a yellow light-emitting region may include multiple materials that emit red and green light when each material is used alone in an OLED device. When used in a yellow device, the individual materials are typically not arranged so that they can be activated or addressed independently. That is, a "yellow" OLED stack containing the materials cannot be driven to produce red, green, or yellow light, but rather the entire stack can be driven to produce yellow light. Such a light-emitting region may be referred to as a yellow light-emitting region even if, at the level of the individual emitters, the stack does not directly produce yellow light. As described in more detail below, the individual light-emitting materials used in a light-emitting region (if more than one) may be located in the same light-emitting layer in the device, or in multiple light-emitting layers in the OLED device that includes the light-emitting region. As described in more detail below, the embodiments disclosed herein may enable OLED devices, such as displays, that include more colors of subpixels or other OLED devices than the number of colors of the light-emitting region, while still including a limited number of colors of the light-emitting region. For example, the devices disclosed herein may include only blue and yellow light-emitting regions. The additional colors of the subpixels may be achieved through the use of color changing layers, such as color changing layers disposed in a stack with yellow or blue light emitting regions, or more generally, through the use of color changing layers, electrodes or other structures forming microcavities as disclosed herein, or any other suitable configuration. In some cases, the general color provided by the subpixel may be the same as the color provided by the light emitting regions in the stack defining the subpixel, such as when a dark blue color changing layer is disposed in a stack with a light blue light emitting region to produce a dark blue subpixel. Similarly, the color provided by the subpixel may differ from the color provided by the light emitting regions in the stack defining the subpixel, such as when a green color changing layer is disposed in a stack with a yellow light emitting region to produce a green subpixel.

[0069] In some configurations, the light-emitting region and / or light-emitting layer can span multiple subpixels, and additional layers and circuitry can be fabricated to allow portions of the light-emitting region or layer to be individually addressed.

[0070] The light-emitting regions disclosed herein can be distinguished from light-emitting "layers" as commonly referred to in the art and used herein. In some cases, a single light-emitting region may include multiple layers, such as when a yellow light-emitting region is fabricated by sequentially depositing red and green light-emitting layers to form a yellow light-emitting region. As previously mentioned, when such layers are present in a light-emitting region as disclosed herein, the layers are not individually addressable within a single light-emitting stack; rather, the layers are activated or driven simultaneously to generate the desired color of light for the light-emitting region. In other configurations, the light-emitting region may include a single light-emitting layer of a single color or multiple light-emitting layers of the same color, where the color of such light-emitting layer is the same as the color of the light-emitting region in which the light-emitting layer is disposed, or in the same region of the spectrum as the color of the light-emitting region in which the light-emitting layer is disposed.

[0071] B. OLEDs and Devices of the Present Disclosure Boron-containing E-hosts, such as those with the OBO core of formula II, have shallower LUMO energy compared to E-hosts that utilize triazine cores.Therefore, when used as E-hosts in OLEDs, OBOs have reduced exciplex formation compared to commonly used deep LUMO E-hosts such as triazines.This reduced exciplex formation leads to more saturated color and potentially blue-shifted emission, as well as increased efficiency of OLED devices.In addition, due to their extended conjugation and planar nature, OBOs can have high electron mobility, resulting in lower device operating voltages.

[0072] However, OLEDs utilizing OBO as the E host often suffer from reduced device lifetimes compared to OLEDs using triazines. The adverse effect on lifetime may be due to multiple reasons not all of which are listed here, but one reason may be related to their shallower LUMO energy. Another reason may be related to the reactivity of boron atoms with reactive sites on the emitter or reactive sites on other compounds present in the emissive layer of the EML. In some embodiments, such reactive sites on the emitter may be sites with LUMO density thereon, and in some embodiments, such reactive sites with LUMO density thereon include pyridine, pyrimidine, benzimidazole, imidazole, and triazine.

[0073] In some embodiments, sterically bulky groups are added to the emitter at or near the reactive sites to reduce the likelihood of interaction with the boron centers on the E host. In some embodiments, sterically bulky groups are added to the boron-containing E host to reduce the likelihood of interaction with the reactive sites on the emitter.

[0074] The present disclosure provides an OLED having an OBO E-host of formula II and a Pt-tetradentate emitter of formula I, which exhibits increased device lifetime as a result of the addition of bulky emitters around the pyridine reactive sites.

[0075] An OLED according to an embodiment of the present disclosure includes an anode; a cathode; and an emissive layer disposed between the anode and the cathode; the emissive layer includes a first compound and a second compound; the first compound has a structure of Formula I: [ka] where each of moieties A, B, C and D is independently a monocyclic ring or a polycyclic fused ring system, and each ring of the monocyclic ring or polycyclic fused ring system is independently a 5- or 6-membered, carbocyclic or heterocyclic ring; X 1 ~X 5each is independently C or N; K 1 , K 2 , and K 3 Each of R α ), P(R α ), B(R α ), C(R α )(R β ) and Si(R α )(R β ) selected from the group consisting of; m and n are each independently 0 or 1; m+n=1 or 2; The second compound has the structure of Formula II: [ka] having; where Z 1 ~Z 11 each is independently C or N; x and y are each independently 0 or 1; wherein the LUMO energy of the second compound is −2.33 eV or less; Where: L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 each is independently a direct bond or a linker selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=C=CR''R''', S=O, SO2, CR, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; R A , R B , R C , R D , R E , R F , and R G each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; Rα , R β , R, R', R'', R''', R A , R B , R C , R D , R E , R F , and R G each is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and Any two substituents may be joined or fused to form a ring; at least one of the following conditions is true: In formula (1), at least one R D The substituent is not hydrogen; (2) wherein one of moieties A, B, C, or D of formula I contains a pyridine moiety coordinated to Pt, the pyridine moiety having a center of mass C1; the nearest calculated intermolecular distance at 0 K between C1 and the boron atom of formula II is 3.57 Å or greater; (3) In the formula II, R E , R G , or R F at least one of has a spherocity of 0.04 or greater and the LUMO energy of formula II is -2.33 eV or less; and (4) Moiety A is benzimidazole, moieties B and C are each phenyl, moiety D is pyridine, and X 1 If is N, then at least one of the following two conditions is true: (a) at least one R that is not hydrogen D The combined molecular weight of all of the substituents is >57 g / mol; or (b) Two R’s D The substituents are joined together to form a ring.

[0076] In some embodiments, condition (2) is true. In some embodiments, condition (3) is true. In some embodiments, conditions (1) and (2) are both true. In some embodiments, conditions (1) and (3) are both true. In some embodiments, conditions (1) and (4) are both true. In some embodiments, conditions (2) and (3) are both true. In some embodiments, conditions (2) and (4) are both true. In some embodiments, conditions (3) and (4) are both true. In some embodiments, all conditions are true.

[0077] In some embodiments, each R α , R β , R, R', R'', R''', R A , R B , R C , R D , R E , R F , and R G is independently hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.

[0078] In some embodiments, each of moieties A, B, C, and D is independently selected from benzene, pyridine, pyrimidine, pyridazine, pyrazine, triazine, imidazole, imidazole derived carbene, pyrazole, pyrrole, oxazole, furan, thiophene, thiazole, triazole, naphthalene, quinoline, isoquinoline, quinazoline, benzofuran, aza-benzofuran, benzoxazole, aza-benzoxazole, benzothiophene, aza-benzothiophene, benzothiazole, aza-benzothiazole, benzoselenophene, , aza-benzoselenophene, indene, aza-indene, indole, aza-indole, benzimidazole, aza-benzimidazole, benzimidazole derived carbene, aza-benzimidazole derived carbene, carbazole, aza-carbazole, dibenzofuran, aza-dibenzofuran, dibenzothiophene, aza-dibenzothiophene, quinoxaline, phthalazine, phenanthrene, aza-phenanthrene, anthracene, aza-anthracene, phenanthridine, fluorene, and aza-fluorene.

[0079] In some embodiments, the moiety A is a monocyclic ring.

[0080] In some embodiments, moiety A is a polycyclic fused ring system.

[0081] In some embodiments, X 1 and X 2 is an N-heterocyclic carbene ligand.

[0082] In some embodiments, X 1 is C and X 2 is N. In some embodiments, X 1 is N and X 2 is C.

[0083] In some embodiments, X 3 is C and X 4 is C.

[0084] In some embodiments, moiety B is a monocyclic ring. In some embodiments, moiety B is benzene. In some embodiments, moiety B is a polycyclic fused ring system.

[0085] In some embodiments, X 5 is C.

[0086] In some embodiments, moiety C is a monocyclic ring. In some embodiments, moiety C is benzene. In some embodiments, moiety C is a polycyclic fused ring system.

[0087] In some embodiments, moiety D is a monocyclic ring. In some embodiments, moiety D is a pyridine. In some embodiments, moiety D is a polycyclic fused ring system.

[0088] In some embodiments, L 1 is a direct bond. In some embodiments, L 1 is selected from the group consisting of O, S, and Se. In some embodiments, L 1 is selected from the group consisting of BR, NR, and PR. 1 is selected from the group consisting of BRR′, CRR′, SiRR′, and GeRR′. In some embodiments, L 1 is selected from the group consisting of P(O)R, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, and CR. 1 is selected from the group consisting of alkyl, cycloalkyl, aryl, and heteroaryl.

[0089] In some embodiments, n in formula I is 0. In some embodiments, n is 1.

[0090] In some embodiments, L 2 is a direct bond. In some embodiments, L 2 is selected from the group consisting of O, S, and Se. In some embodiments, L 2is selected from the group consisting of BR, NR, and PR. 2 is selected from the group consisting of BRR′, CRR′, SiRR′ and GeRR′. In some embodiments, L 2 is selected from the group consisting of P(O)R, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, and CR. 2 is selected from the group consisting of alkyl, cycloalkyl, aryl, and heteroaryl.

[0091] In some embodiments, L 3 is a direct bond. In some embodiments, L 3 is selected from the group consisting of O, S, and Se. In some embodiments, L 3 is selected from the group consisting of BR, NR, and PR. 3 is selected from the group consisting of BRR′, CRR′, SiRR′, and GeRR′. In some embodiments, L 3 is selected from the group consisting of P(O)R, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, and CR. 3 is selected from the group consisting of alkyl, cycloalkyl, aryl, and heteroaryl.

[0092] In some embodiments, m in formula I is 0. In some embodiments, m is 1.

[0093] In some embodiments, L 4 is a direct bond. In some embodiments, L 4 is selected from the group consisting of O, S, and Se. In some embodiments, L 4 is selected from the group consisting of BR, NR, and PR. 4 is selected from the group consisting of BRR′, CRR′, SiRR′ and GeRR′. In some embodiments, L 4is selected from the group consisting of P(O)R, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, and CR. 4 is selected from the group consisting of alkyl, cycloalkyl, aryl, and heteroaryl.

[0094] In some embodiments, K 1 is a direct bond. In some embodiments, K 1 is selected from the group consisting of O and S. In some embodiments, K 1 is N(R α ), P(R α ), and B(R α In some embodiments, K 1 is C(R α )(R β ), and Si(R α )(R β ).

[0095] In some embodiments, K 2 is a direct bond. In some embodiments, K 2 is selected from the group consisting of O and S. In some embodiments, K 2 is N(R α ), P(R α ), and B(R α In some embodiments, K 2 is C(R α )(R β ), and Si(R α )(R β ).

[0096] In some embodiments, K 3 is a direct bond. In some embodiments, K 3 is selected from the group consisting of O and S. In some embodiments, K 3 is N(R α ), P(R α ), and B(R α In some embodiments, K3 is C(R α )(R β ), and Si(R α )(R β ).

[0097] In some embodiments, K 1 , K 2 , and K 3 Each of K is a direct bond. 1 , K 2 , or K 3 One of them is O, S, N(R α ), P(R α ), B(R α ), C(R α )(R β ), and Si(R α )(R β ), K 1 , K 2 , and K 3 The other two are direct bonds.

[0098] In some embodiments, moiety A is benzimidazole, moiety B and moiety C are each phenyl, moiety D is pyridine, and X 1 is N.

[0099] In some embodiments, at least one R A The substituents are not hydrogen. In some embodiments, at least one R A has a molecular weight of at least 57 g / mol.

[0100] In some embodiments, at least one R B The substituents are not hydrogen. In some embodiments, at least one R C The substituent is not hydrogen.

[0101] In some embodiments, at least one R is not hydrogen. D The molecular weight of each of the substituents is ≧57 g / mol. In some embodiments, at least one R DThe total molecular weight of all of the substituents is ≧77 g / mol.

[0102] In some embodiments, at least one R D is a bulky group. In some embodiments, at least one R D is the following structure in Listing 1: [ka] [ka] wherein each Y aa and Y bb is independently selected from the group consisting of a direct bond, BR, BRR', NR, PR, O, S, Se, C=O, C=S, C=Se, C=NR, C=CRR', S=O, SO2, CR, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; Q A , Q B , Q C , Q D , and Q E each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; Each R, R', Q A , Q B , Q C , Q D , Q E , Q A1 , Q B1 , Q C1 , Q D1 , and Q E1 is independently hydrogen or a substituent selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and Any two substituents can be joined or fused to form a ring.

[0103] In some embodiments, at least one R D is the following structure in Listing 2: [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] wherein Ph represents phenyl.

[0104] In some embodiments, exactly one R D is not hydrogen. In some embodiments, two R DThe substituents are joined together to form a ring that is fused to the D moiety.

[0105] In some embodiments, the first compound is partially or fully deuterated.

[0106] In some embodiments, the first compound comprises one or more electron-withdrawing groups, which in some embodiments generally comprise one or more highly electronegative elements, including, but not limited to, fluorine, oxygen, sulfur, nitrogen, chlorine, and bromine.

[0107] In some embodiments, electron withdrawing groups have a Hammett constant greater than 0. In some embodiments, electron withdrawing groups have a Hammett constant greater than or equal to 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, or 1.1.

[0108] In some embodiments, the first compound has a structure selected from the following EWG1 list: F, CF3, CN, COCH3, CHO, COCF3, COOMe, COOCF3, NO2, SF3, SiF3, PF4, SF5, OCF3, SCF3, SeCF3, SOCF3, SeOCF3, SO2F, SO2CF3, SeO2CF3, OSeO2CF3, OCN, SCN, SeCN, NC, + N(R k2 )3, (R k2 )2CCN, (R k2 )2CCF3, CNC(CF3)2, BR k3 R k2, substituted or unsubstituted dibenzoborole, 1-substituted carbazole, 1,9-substituted carbazole, substituted or unsubstituted carbazole, substituted or unsubstituted pyridine, substituted or unsubstituted pyrimidine, substituted or unsubstituted pyrazine, substituted or unsubstituted pyridoxine, substituted or unsubstituted triazine, substituted or unsubstituted oxazole, substituted or unsubstituted benzoxazole, substituted or unsubstituted thiazole, substituted or unsubstituted benzothiazole, substituted or unsubstituted imidazole, substituted or unsubstituted benzimidazole, ketones, carboxylic acids, esters, nitriles, isonitriles, sulfinyls, sulfonyls, partially and fully fluorinated alkyls, partially and fully fluorinated aryls, partially and fully fluorinated heteroaryls, cyano-containing alkyls, cyano-containing aryls, cyano-containing heteroaryls, isocyanates, [ka] and one or more electron withdrawing groups selected from the group consisting of Here, each R k1 represents a single substitution up to the maximum allowed substitution, or no substitution; Here, Y G BR e , N.R. e , P.R. e , O, S, Se, C=O, S=O, SO2, CR e R f , SiR e R f , and GeR e R f’ selected from the group consisting of: Here, R k1 , R k2 , R k3 , R e , and R f Each of is independently hydrogen or a substituent selected from the group consisting of general substituents defined herein.

[0109] In some embodiments, the first compound has a structure in the EWG2 list below: [ka] [ka] [ka] [ka] The compound comprises one or more electron withdrawing groups selected from the group consisting of:

[0110] In some embodiments, the first compound has a structure from the EWG3 list: [ka] [ka] The compound comprises one or more electron withdrawing groups selected from the group consisting of:

[0111] In some embodiments, the first compound has a structure from the EWG4 list below: [ka] The compound comprises one or more electron withdrawing groups selected from the group consisting of:

[0112] In some embodiments, the first compound comprises one or more π-electron deficient electron withdrawing groups. In some embodiments, the first compound comprises a structure from the following Pi-EWG list: CN, COCH3, CHO, COCF3, COOMe, COOCF3, NO2, SF3, SiF3, PF4, SF5, OCF3, SCF3, SeCF3, SOCF3, SeOCF3, SO2F, SO2CF3, SeO2CF3, OSeO2CF3, OCN, SCN, SeCN, NC, + N(R k2 )3, BR k2 R k3, substituted or unsubstituted dibenzoborole, 1-substituted carbazole, 1,9-substituted carbazole, substituted or unsubstituted carbazole, substituted or unsubstituted pyridine, substituted or unsubstituted pyrimidine, substituted or unsubstituted pyrazine, substituted or unsubstituted pyridazine, substituted or unsubstituted triazine, substituted or unsubstituted oxazole, substituted or unsubstituted benzoxazole, substituted or unsubstituted thiazole, substituted or unsubstituted benzothiazole, substituted or unsubstituted imidazole, substituted or unsubstituted benzimidazole, ketones, carboxylic acids, esters, nitriles, isonitriles, sulfinyls, sulfonyls, partially and fully fluorinated aryls, partially and fully fluorinated heteroaryls, cyano-containing aryls, cyano-containing heteroaryls, isocyanates, [ka] wherein the variables are the same as previously defined.

[0113] In some embodiments, R A , R B , R C , or R D At least one of R is an electron withdrawing group from the EWG1 list as defined herein. A , R B , R C , or R D At least one of R is an electron withdrawing group from the EWG2 list as defined herein. A , R B , R C , or R D At least one of R is an electron withdrawing group from the EWG3 list as defined herein. A , R B , R C , or R D At least one of R is an electron withdrawing group from the EWG4 list as defined herein. A , R B , R C , or RD At least one of is an electron withdrawing group from the Pi-EWG list as defined herein.

[0114] In some embodiments, at least one R A is an electron withdrawing group from the EWG1 list as defined herein. In some embodiments, at least one R A is an electron withdrawing group from the EWG2 list as defined herein. In some embodiments, at least one R A is an electron withdrawing group from the EWG3 list as defined herein. In some embodiments, at least one R A is an electron withdrawing group from the EWG4 list as defined herein. In some embodiments, at least one R A is an electron withdrawing group from the Pi-EWG list as defined herein.

[0115] In some embodiments, at least one R B is an electron withdrawing group from the EWG1 list as defined herein. In some embodiments, at least one R B is an electron withdrawing group from the EWG2 list as defined herein. In some embodiments, at least one R B is an electron withdrawing group from the EWG3 list as defined herein. In some embodiments, at least one R B is an electron withdrawing group from the EWG4 list as defined herein. In some embodiments, at least one R B is an electron withdrawing group from the Pi-EWG list as defined herein.

[0116] In some embodiments, at least one R C is an electron withdrawing group from the EWG1 list as defined herein. In some embodiments, at least one R C is an electron withdrawing group from the EWG2 list as defined herein. In some embodiments, at least one R Cis an electron withdrawing group from the EWG3 list as defined herein. In some embodiments, at least one R C is an electron withdrawing group from the EWG4 list as defined herein. In some embodiments, at least one R C is an electron withdrawing group from the Pi-EWG list as defined herein.

[0117] In some embodiments, at least one R D is an electron withdrawing group from the EWG1 list as defined herein. In some embodiments, at least one R D is an electron withdrawing group from the EWG2 list as defined herein. In some embodiments, at least one R D is an electron withdrawing group from the EWG3 list as defined herein. In some embodiments, at least one R D is an electron withdrawing group from the EWG4 list as defined herein. In some embodiments, at least one R D is an electron withdrawing group from the Pi-EWG list as defined herein.

[0118] In some embodiments, the first compound is partially or fully deuterated. In some embodiments, the first compound is fully deuterated. In some embodiments, the first compound is partially deuterated.

[0119] In some embodiments, the first compound has the structure of List 3 below: [ka] [ka] [ka] [ka] [ka] [ka] [ka] having a structure selected from the group consisting of: Where: X 6 ~X 9 each is independently C or N; K is a direct bond, O, S, N(R α ), P(R α ), B(R α ), C(R α )(R β ), and Si(R α )(R β ) selected from the group consisting of; L is a direct bond or a linker selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, CR, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; Y A and Y B each is independently selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, CR, CRR', SiRR', GeRR'; R AA , R BB , R CC , and R DD each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; Each R, R', R'', R''', R α , R β , R X , R Y , R A1 , R D1 , R G1 , R G2 , R G3 , R G4 , R G5 , R G6, R G7 , R G8 , R AA , R BB , R CC , and R DD is independently hydrogen or a substituent selected from the group consisting of general substituents defined herein; and Any two substituents can be joined or fused to form a ring.

[0120] In some embodiments, the first compound has the structure of List 4 below: [ka] [ka] [ka] [ka] [ka] [ka] having a structure selected from the group consisting of: Where: K is a direct bond, O, S, N(R α ), P(R α ), B(R α ), C(R α )(R β ), and Si(R α )(R β ) selected from the group consisting of; L is a direct bond or a linker selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, CR, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; Y A and Y Beach is independently selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, CR, CRR', SiRR', GeRR'; R AA , R BB , R CC , and R DD each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; Each R, R', R'', R''', R α , R β , R X , R Y , R A1 , R D1 , R G1 , R G2 , R G3 , R G4 , R G5 , R G6 , R G7 , R G8 , R AA , R BB , R CC , and R DD is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and Any two substituents can be joined or fused to form a ring.

[0121] In some embodiments, the first compound has the structure of Formula XI or Formula XII: [ka] where: X 5’ ~X 11’ are each independently C or N; R EE represents a single substitution up to the maximum allowed substitution, or no substitution; R E , R EE0 , R EE1 and R EE2 each is independently hydrogen or a substituent selected from the group consisting of general substituents defined herein; and Any two substituents can be joined or fused to form a ring.

[0122] In some embodiments, R EE0 is selected from the group consisting of halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof. EE0 is not H or D. In some embodiments, R EE0 is alkyl, cycloalkyl, aryl, or heteroaryl. In some embodiments, R EE0 is C6H5, C6D5, C(CH3)3, C(CD3)3, CD2C(CH3)3, CH3, CD3, cyclopentyl, cyclohexyl, or neopentyl.

[0123] In some embodiments, X 5’ ~X 11’ Each of X is C. In some embodiments, 5’ ~X 11’ is N. In some embodiments, X 5’ ~X 11’ Two of X are N. In some embodiments, 5’ ~X 8’ is N. In some embodiments, X 9’ and X 11’ is N. In some embodiments, X 10’is N.

[0124] In some embodiments, R EE1 is R EE2 In some embodiments, R EE1 is R EE2 is different.

[0125] In some embodiments, R EE1 or R EE2 At least one of R comprises a chemical group that includes at least three six-membered aromatic rings that are not fused adjacent to one another. EE1 or R EE2 At least one of R comprises a chemical group that includes at least four six-membered aromatic rings that are not fused adjacent to one another. EE1 or R EE2 At least one of R comprises a chemical group that includes at least five six-membered aromatic rings that are not fused adjacent to one another. EE1 or R EE2 At least one of R comprises a chemical group that includes at least six six-membered aromatic rings that are not fused adjacent to one another. EE1 and R EE2 each independently comprises a chemical group that includes at least three to six six-membered aromatic rings that are not adjacent and fused to one another.

[0126] In some embodiments, R EE1 or R EE2 At least one of the groups R W Including R W Formula XIIIA, ---Q A (R 1a )(R 2a ) a (R 3a ) b , formula XIIIB, [ka] and formula XIIIC, [ka] wherein the structure is selected from the group consisting of X 130 ~X 138 each is independently C or N; Y S , Y T , Y U each is independently CRR′, SiRR′, or GeRR′; n is an integer from 1 to 8, If n is greater than 1, then each Y S may be the same or different; Q A is selected from the group consisting of C, Si, Ge, N, P, O, S, Se, and B; Each of a and b is independently 0 or 1; Q A For C, Si, and Ge, a+b=2; Q A If is N or P, then a+b=1; Q A If is B, then a+b is 1 or 2; Q A When is O, S, or Se, a+b=0; R SS , R TT , and R UU each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; Each R, R', R 1a , R 2a , R 3a , R SS , R TT , and R UU is independently hydrogen or a substituent selected from the group consisting of general substituents defined herein; and Any two substituents may optionally be fused or joined to form a ring.

[0127] In some embodiments, at least one Y S , Y T , or Y U is SiRR′ or GeRR′. In some embodiments, each Y S , Y T , and YU is CRR'.

[0128] In some embodiments, R EE1 and R EE2 At least one of the groups R W In some embodiments, R EE1 and R EE2 Each of the groups R W In some embodiments, R EE1 and R EE2 Each of the formulas comprises XIIIA. In some embodiments, R EE1 and R EE2 Each of the formulas comprises XIIIB. In some embodiments, R EE1 and R EE2 Each of the formulas comprises XIIIC. In some embodiments, R EE1 or R EE2 Any of the groups represented by the formula XIIIA, EE1 and R EE2 The other of the formulas comprises formula XIIIB. EE1 or R EE2 Any of the groups represented by the formula XIIIA, EE1 and R EE2 The other of the formulas comprises formula XIIIC. EE1 or R EE2 Any of the groups represented by the formula XIIIB, EE1 and R EE2 The other comprises formula XIIIC.

[0129] In some embodiments, R EE1 has a molecular weight (MW) greater than 15 g / mol, and R EE2 is R EE1 In some embodiments, R EE1 has a molecular weight (MW) greater than 56 g / mol, and R EE2 is R EE1 In some embodiments, R EE1 has a molecular weight (MW) greater than 76 g / mol, and R EE2 is R EE1In some embodiments, R EE1 has a molecular weight (MW) greater than 81 g / mol, and R EE2 is R EE1 In some embodiments, R EE1 or R EE2 has a molecular weight (MW) greater than 165 g / mol. EE1 or R EE2 has a molecular weight (MW) greater than 166 g / mol. EE1 or R EE2 has a molecular weight (MW) of greater than 182 g / mol.

[0130] In some embodiments, R EE1 is R EE2 In some embodiments, R EE1 is R EE2 In some embodiments, R EE1 is R EE2 In some embodiments, R EE1 is R EE2 In some embodiments, R EE1 is R EE2 It has five more six-membered aromatic rings.

[0131] In some embodiments, R EE1 contains at least one heteroatom, and R EE2 consists of hydrocarbons and deuterated variants thereof. In some embodiments, R EE1 contains at least two heteroatoms, and R EE2 consists of hydrocarbons and deuterated variants thereof. In some embodiments, R EE1 contains at least three heteroatoms, and R EE2 consists of hydrocarbons and deuterated variants thereof. In some embodiments, R EE1 contains exactly one heteroatom and R EE2consists of hydrocarbons and deuterated variants thereof. In some embodiments, R EE1 contains exactly two heteroatoms and R EE2 consists of hydrocarbons and deuterated variants thereof. In some embodiments, R EE1 contains exactly three heteroatoms and R EE2 consists of hydrocarbons and deuterated variants thereof. In some embodiments, R EE1 contains exactly one heteroatom and R EE2 is R EE1 In some embodiments, R EE1 contains exactly one heteroatom and R EE2 is R EE1 Contains exactly one heteroatom identical to the heteroatom in

[0132] In some embodiments, R EE1 contains exactly two heteroatoms and R EE2 In some embodiments, R EE1 contains exactly two heteroatoms and R EE2 In some embodiments, R EE1 contains exactly three heteroatoms and R EE2 In some embodiments, R EE1 contains exactly three heteroatoms and R EE2 In some embodiments, R EE1 contains exactly three heteroatoms and R EE2 contains exactly three heteroatoms.

[0133] In some embodiments, R EE1 and R EE2 At least one of R comprises an aromatic ring fused to a non-aromatic ring. EE1 and R EE2 Both of the formulas include an aromatic ring fused to a non-aromatic ring. In some embodiments, the aromatic ring is a phenyl ring and the non-aromatic ring is a cycloalkyl ring.

[0134] In some embodiments, R EE1 and R EE2 At least one of R is partially or fully deuterated. EE1 and R EE2 Both are partially or fully deuterated.

[0135] In some embodiments, R EE1 and R EE2 One of them is R A It bonds to form a cyclic ring.

[0136] In some embodiments, the first compound has Formula XIV or Formula XV: [ka] and Where: X 12’ ~X 19’ are each independently C or N; R EE3 is independently hydrogen or a substituent selected from the group consisting of general substituents defined herein; and any two substituents can be joined or fused to form a ring.

[0137] In some embodiments, X 12’ ~X 19’ are each C. In some embodiments, X 12’ ~X 19’ is N. In some embodiments, X 12’ ~X 19’ are N. In some embodiments, X 12’ ~X 15’ is N. In some embodiments, X 16’ ~X 19’ One of them is N.

[0138] In some embodiments, the first compound has the structure of List 5 below: [ka] [ka] [ka] [ka] It has a structure consisting of:

[0139] In some embodiments, the LUMO energy of the second compound is -2.40 eV or less. In some embodiments, the LUMO energy of the second compound is -2.45 eV or less. In some embodiments, the LUMO energy of the second compound is -2.50 eV or less. In some embodiments, the LUMO energy of the second compound is -2.55 eV or less. In some embodiments, the LUMO energy of the second compound is -2.60 eV or less. In some embodiments, the LUMO energy of the second compound is -2.65 eV or less.

[0140] In some embodiments, the second compound is a host. In some embodiments, the second compound is an E host.

[0141] In some embodiments, the second compound is partially or fully deuterated. In some embodiments, the second compound is partially deuterated. In some embodiments, the second compound is fully deuterated.

[0142] In some embodiments, Z 1 ~Z 11 Each of is C.

[0143] In some embodiments, Z 1 ~Z 3 Each of Z is C. 1 ~Z 3 At least one of Z is N. 1 ~Z 3Exactly one of is N.

[0144] In some embodiments, Z 4 ~Z 7 Each of Z is C. 4 ~Z 7 At least one of Z is N. 4 ~Z 7 Exactly one of is N.

[0145] In some embodiments, Z 8 ~Z 11 Each of Z is C. 8 ~Z 11 At least one of Z is N. 8 ~Z 11 Exactly one of is N.

[0146] In some embodiments, x+y=2. In some embodiments, x+y=1. In some embodiments, x+y=0.

[0147] In some embodiments, L 5 is a direct bond.

[0148] In some embodiments, L 5 is a direct bond or a linker selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, CR, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.

[0149] In some embodiments, L 5 is selected from the group consisting of O, S, and Se. In some embodiments, L 5 is selected from the group consisting of BR, NR, and PR. 5is selected from the group consisting of BRR′, CRR′, SiRR′, and GeRR′. In some embodiments, L 5 is selected from the group consisting of P(O)R, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, and CR. 5 is selected from the group consisting of alkyl, cycloalkyl, aryl, and heteroaryl.

[0150] In some embodiments, L 6 is a direct bond.

[0151] In some embodiments, L 6 is a direct bond or a linker selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, CR, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.

[0152] In some embodiments, L 6 is selected from the group consisting of O, S, and Se. In some embodiments, L 6 is selected from the group consisting of BR, NR, and PR. 6 is selected from the group consisting of BRR′, CRR′, SiRR′, and GeRR′. In some embodiments, L 6 is selected from the group consisting of P(O)R, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO2, and CR. 6 is selected from the group consisting of alkyl, cycloalkyl, aryl, and heteroaryl.

[0153] In some embodiments, at least one R E , R F , or R Gincludes a moiety selected from the group consisting of aryl, heteroaryl, silyl, amino, combinations thereof, and partially and fully deuterated variants thereof.

[0154] In some embodiments, at least one R E is not hydrogen. In some embodiments, at least one R E includes a moiety selected from the group consisting of aryl, heteroaryl, silyl, amino, combinations thereof, and partially and fully deuterated variants thereof.

[0155] In some embodiments, at least one R F is not hydrogen. In some embodiments, at least one R F includes a moiety selected from the group consisting of aryl, heteroaryl, silyl, amino, combinations thereof, and partially and fully deuterated variants thereof.

[0156] In some embodiments, at least one R G is not hydrogen. In some embodiments, at least one R G includes a moiety selected from the group consisting of aryl, heteroaryl, silyl, amino, combinations thereof, and partially and fully deuterated variants thereof.

[0157] In some embodiments, two adjacent R E are bonded or condensed to form a ring.

[0158] In some embodiments, two adjacent R F are bonded or condensed to form a ring.

[0159] In some embodiments, two adjacent R G are bonded or condensed to form a ring.

[0160] In some embodiments, the second compound has the structure of List 6 below: [ka] [ka] is selected from Where: Z 30 , Z 31 , and Z 32 each is independently C or N; Each Y A is independently selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CRR, S=O, SO2, CRR', SiRR', and GeRR'; R EE , R FF , R GG , R JJ , R KK , and R LL each independently represents from a single substitution to maximal substitution or no substitution; R, R', R EE , R FF , R GG , R JJ , R KK , and R LL each is independently hydrogen or a substituent selected from the group consisting of general substituents defined herein; and Any two adjacent substituents can be joined or fused to form a ring.

[0161] In some embodiments, the second compound has the structure of List 7 below: [ka] [ka] [ka] is selected from Where: Each Y Ais independently selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CRR, S=O, SO2, CRR', SiRR', and GeRR'; R EE , R FF , R JJ , R KK , and R LL each independently represents from a single substitution to maximal substitution or no substitution; R, R', R EE , R FF , R JJ , R KK , and R LL each is independently hydrogen or a substituent selected from the group consisting of general substituents defined herein; and Any two adjacent substituents can be joined or fused to form a ring.

[0162] In some embodiments, the second compound has the structure of List 8 below: [ka] [ka] [ka] [ka] is selected from.

[0163] In some embodiments, one of moieties A, B, C, or D of formula I comprises a pyridine moiety coordinated to Pt and having a center of gravity C1, where the nearest calculated intermolecular distance at 0 K between C1 and the boron atom of formula II is 3.57 Å or greater.

[0164] In some embodiments of the device, the nearest calculated intermolecular contact at 0 K between a boron atom of the host and the center of the pyridine ring of the Pt complex is 3.60 Å or greater. In some embodiments of the device, the nearest calculated intermolecular contact at 0 K between a boron atom of the host and the center of the pyridine ring of the Pt complex is 4.50 Å or greater. In some embodiments of the device, the nearest calculated intermolecular contact at 0 K between a boron atom of the host and the center of the pyridine ring of the Pt complex is 10.57 Å or greater.

[0165] To measure the distance of this intermolecular close contact, it is necessary to find low-energy dyads between a boron-containing host and a Pt emitter that occur in the emissive layer of an OLED device. The following procedure was used to model the most favorable low-energy dyad structures. The ground-state B3LYP structures, along with the adsorption locator tool, served as input for annealing sampling of molecular pairs simulated with Metropolis Monte Carlo using BIOVIA Materials Studio 2022, Release 22.1. A universal force field was used in each Monte Carlo simulation, and electrostatic interactions were described by extracting Hirshfeld charges fitted to dipole moments from single-point DM013 calculations with the PW91 functional using the DNP basis set. A total of 10 heating cycles were used in each simulation, with 500,000 molecular pair configurations sampled in each cycle using automated temperature control. The lowest 50 pairs were returned from each intermolecular pair simulation. For these pairs, within 2 kcal / mol of the lowest pair, the nearest intermolecular contact between the boron atom of the host and the center of the pyridine ring of the Pt emitter was probed in Angstroms.

[0166] Figure 4a shows the interaction between EH2 and D1, indicating that the pyridine ring of formula I is not protected and can easily interact with the boron atom of EH2. Figure 4b shows the interaction between EH2 and D2, indicating that the bulky t-butyl group at the 3-position of the pyridine ring protects the pyridine by reducing the interaction between the pyridine of D2 and the boron atom of EH2. Figure 4c shows the interaction between EH1 and D1, indicating that the boron atom is sterically protected from both sides of the E-host. It is believed that the device lifetime of blue systems can be increased by reducing the interaction between the boron-containing E-host and the Pt containing blue dopant. The structures of EH1, EH2, D1 and D2 are shown below: [ka]

[0167] In some embodiments, R of formula II E , R G , or R F At least one of R in Formula II has a sphericity of 0.04 or greater. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.25. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.3. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.35. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.4. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.45. E, R G , or R F At least one of R in Formula II has a sphericity of greater than 0.5. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.55. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.6. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.65. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.7. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.75. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.8. E , R G , or R F At least one of R in Formula II has a sphericity of greater than 0.85. E , R G , or R F At least one of the particles has a sphericity greater than 0.9.

[0168] Sphericity is a measure of the three-dimensionality of bulky groups. Sphericity is defined as the ratio between the principal moments of inertia (PMI). Specifically, sphericity is the ratio of 3 times PMI1 to the sum of PMI1, PMI2, and PMI3, where PMI1 is the smallest principal moment of inertia, PMI2 is the second smallest principal moment of inertia, and PMI3 is the largest principal moment of inertia. The sphericity of the lowest energy conformer of the structure after optimizing the ground state with density functional theory can be calculated. More detailed information can be found in paragraphs

[0054] to

[0059] of U.S. Application No. 18 / 062,110, filed December 6, 2022, the contents of which are incorporated herein by reference.

[0169] In some embodiments, R E , R F or R G At least one of the structures in List 6a below: [ka] [ka] selected from the group consisting of; Where: Z 1 ~Z 202 are each independently C or N; A1 is selected from the group consisting of BR, BRR', NR, PR, O, S, Se, C=O, C=S, C=Se, C=NR, C=CRR', S=O, SO2, CR, CRR', SiRR', and GeRR'; W independently represent a single substitution up to the maximum allowable substitution, or no substitution; each R, R′, and R Ware independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and any two R W can be linked or fused to form a ring.

[0170] In some embodiments, the boron-containing E-host of formula II includes a sterically bulky group on one side of the boron-containing face. In these embodiments, the boron-containing face is defined as the face that includes the OBO moiety. In some embodiments, the boron-containing E-host of formula II includes a sterically bulky group on both sides of the boron-containing face. In some embodiments, the boron-containing E-host of formula II includes a sterically bulky group on both sides of the boron-containing face, resulting in a sandwich-type structure around the face of the OBO. In some of the above embodiments, the sterically bulky group can be formed by combining one or more carbazole molecules in various configurations. In some of the above embodiments, the steric bulk can be formed by combining one or more phenyl molecules in various configurations. In some of the above embodiments, the steric bulk can be formed by combining one or more silane-containing molecules in various configurations. In some such embodiments, these silane-containing molecules can be triphenylsilane or tetraphenylsilane. In some embodiments, the sterically bulky group can be selected from the structures of List 6a defined herein.

[0171] In some embodiments, the first compound can be an emissive or non-emissive dopant. In some embodiments, the emissive dopant can be a phosphorescent or fluorescent material. In some embodiments, the non-emissive dopant can also be a phosphorescent or fluorescent material.

[0172] Phosphorescence generally refers to the emission of photons with a change in electron spin, i.e., the initial and final states of emission have different multiplicities, such as T1 to S0 states. Ir and Pt complexes, which are currently widely used in OLEDs, belong to phosphorescent materials. In some embodiments, when an exciplex formation involves a triplet emitter, such an exciplex can also emit phosphorescence. On the other hand, fluorescent emitters generally refer to the emission of photons without a change in electron spin, such as S1 to S0 states. Fluorescent emitters can be delayed fluorescent emitters or non-delayed fluorescent emitters. Depending on the spin state, fluorescent emitters can be singlet or doublet emitters, or other multiplet emitters. It is believed that the internal quantum efficiency (IQE) of fluorescent OLEDs can exceed the 25% spin statistical limit by delayed fluorescence. There are two types of delayed fluorescence, namely P-type and E-type delayed fluorescence. P-type delayed fluorescence occurs by triplet-triplet annihilation (TTA). On the other hand, E-type delayed fluorescence relies on the thermal population between the triplet state and the singlet excited state, rather than the collision of two triplets. The transition from the triplet state to the singlet state can be activated by thermal energy. This type of delayed fluorescence is also known as thermally activated delayed fluorescence (TADF). The characteristics of E-type delayed fluorescence can be found in exciplex systems or single compounds. Without being bound by theory, TADF has a small singlet-triplet energy gap (ΔE S-T) is believed to be necessary. There are two main types of TADF emitters, one is called donor-acceptor type TADF and the other is called multiple resonance (MR) type TADF. In many cases, a donor-acceptor single compound is constructed by connecting an electron donor moiety, such as an amino derivative or a carbazole derivative, with an electron acceptor moiety, such as an N-containing six-membered aromatic ring. A donor-acceptor exciplex can be formed between a hole transport compound and an electron transport compound. Examples of MR-TADF include highly conjugated boron-containing compounds. In some embodiments, the reverse intersystem crossing time from T1 to S1 of delayed fluorescence emission at 293 K is 10 microseconds or less. In some embodiments, such a time can be greater than 10 microseconds and less than 100 microseconds.

[0173] In some embodiments, the OLED may include an additional compound selected from the group consisting of fluorescent materials, delayed fluorescent materials, phosphorescent materials, and combinations thereof.

[0174] In some embodiments, the phosphorescent material is an emitter that emits light in an OLED. In some embodiments, the phosphorescent material does not emit light in an OLED. In some embodiments, the energy of the phosphorescent material transfers its excited state to another material in an OLED. In some embodiments, the phosphorescent material participates in charge transport in an OLED. In some embodiments, the phosphorescent material is a sensitizer and the OLED further includes an acceptor.

[0175] In some embodiments, the fluorescent material or delayed fluorescent material is an emitter that emits light in the OLED. In some embodiments, the fluorescent material or delayed fluorescent material does not emit light in the OLED. In some embodiments, the energy of the fluorescent material or delayed fluorescent material transfers its excited state to another material in the OLED. In some embodiments, the fluorescent material or delayed fluorescent material participates in charge transport in the OLED. In some embodiments, the fluorescent material or delayed fluorescent material is a sensitizer, and the OLED further includes an acceptor.

[0176] In some embodiments, the first compound is an acceptor and the OLED can further include a sensitizer selected from the group consisting of delayed fluorescent materials, phosphorescent materials, and combinations thereof.

[0177] In some embodiments, the first compound can be a fluorescent emitter, a delayed fluorescent material, or a component of an exciplex that is a fluorescent emitter or a delayed fluorescent material.

[0178] In some embodiments, the second compound is a host and the OLED comprises an acceptor that is an emitter and a sensitizer selected from the group consisting of delayed fluorescent materials, phosphorescent materials, and combinations thereof; where the sensitizer transfers energy to the acceptor.

[0179] In some embodiments, the LUMO energy of Formula II is less than or equal to -2.33 eV.

[0180] In some embodiments, the light-emitting layer includes a third compound, hi some embodiments, the third compound is a light emitter.

[0181] In some embodiments, the first compound is a sensitizer and the third compound is an acceptor.

[0182] In some embodiments, the third compound is a phosphorescent emitter, a fluorescent emitter, a thermally activated delayed fluorescent (TADF) emitter, or any combination thereof.

[0183] In some embodiments, the third compound is a fluorescent emitter. In some embodiments, the third compound is a non-delayed fluorescent emitter. In some embodiments, the third compound is a delayed fluorescent emitter. In some embodiments, the third compound is a P-type delayed fluorescent emitter.

[0184] In some embodiments, the third compound is a delayed fluorescent compound that functions as a TADF emitter at room temperature. In some embodiments, the TADF emitter includes at least one donor group and at least one acceptor group. In some embodiments, the TADF emitter is a metal complex. In some embodiments, the TADF emitter is a non-metal complex. In some embodiments, the TADF emitter is a Cu, Ag, or Au complex.

[0185] In some embodiments, the TADF emitter has the structure of List 9 below: [ka] [ka] at least one chemical moiety selected from the group consisting of: wherein T is selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO2, CRR′, SiRR′, and GeRR′; Each R T may be the same or different, and each R T is independently a donor group, an acceptor group, an organic linker attached to a donor group, an organic linker attached to an acceptor group, or a terminal group selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, aryl, heteroaryl, and combinations thereof; and Each R and R' is independently hydrogen or a substituent selected from the group consisting of general substituents defined herein.

[0186] In some embodiments, the TADF emitter comprises at least one chemical moiety selected from the group consisting of nitriles, isonitriles, boranes, fluorides, pyridines, pyrimidines, pyrazines, triazines, aza-carbazoles, aza-dibenzothiophenes, aza-dibenzofurans, aza-dibenzoselenophenes, aza-triphenylenes, imidazoles, pyrazoles, oxazoles, thiazoles, isoxazoles, isothiazoles, triazoles, thiadiazoles, and oxadiazoles.

[0187] In some embodiments, the light-emitting layer further comprises a fourth compound. In some embodiments, the fourth compound is a host. In some embodiments, the fourth compound is an H host.

[0188] In some embodiments, the light-emitting layer comprises a plurality of light-emitting layers, and at least one of the plurality of light-emitting layers comprises both the first compound and the second compound.

[0189] In some embodiments, the light-emitting layer comprises multiple light-emitting layers, each of the multiple light-emitting layers emitting only a single color.

[0190] In some embodiments, the OLED further comprises at least one layer from the group consisting of a hole injection layer, a hole transport layer, an electron blocking layer, a layer of light emitting material, a hole blocking layer, an electron transport layer, an electron injection layer, and a capping layer.

[0191] In some embodiments, the OLED of the present disclosure includes an emissive region disposed between an anode and a cathode, the emissive region includes a sensitizer compound and an acceptor compound, the sensitizer transferring energy to the acceptor compound, which is an emitter. In some embodiments, the sensitizer compound can emit light from a triplet excited state to a ground singlet state in the OLED at room temperature. In some embodiments, the sensitizer compound can function as a phosphorescent emitter, a TADF emitter, or a doublet emitter in the OLED at room temperature. In some embodiments, the acceptor compound is selected from the group consisting of a delayed fluorescent compound that functions as a TADF emitter in the OLED at room temperature, and a fluorescent compound that functions as a fluorescent emitter in the OLED at room temperature. In some embodiments, the fluorescent emitter can be a singlet or doublet emitter. In some such embodiments, the singlet emitter can include a TADF emitter, and also a multi-resonant MR-TADF emitter. A description of delayed fluorescence as used herein can be found in paragraphs 0083-0084 of U.S. Patent Application Publication US20200373510A1, the entire contents of which are incorporated herein by reference.

[0192] In some embodiments of the OLED, the sensitizer and the acceptor compound are in separate layers within the light-emitting region.

[0193] In some embodiments, the sensitizer and acceptor compounds are present as a mixture in one or more layers in the emissive region. It should be understood that the mixture in a given layer may be a homogeneous mixture, or the compounds in the mixture may be at graded concentrations throughout the thickness of a given layer. The concentration gradient can be linear, non-linear, sinusoidal, etc. If there is more than one layer in the emissive region having a mixture of sensitizer and acceptor compounds, the type of mixture (i.e., uniform or graded concentration) and the concentration levels of the compounds in the mixture in each of the more than one layer may be the same or different. In addition to the sensitizer and acceptor compounds, there may be one or more other functional compounds, such as, but not limited to, a host, also mixed into the mixture.

[0194] In some embodiments, the acceptor compound can be present in two or more layers at the same or different concentrations. In some embodiments, when two or more layers include an acceptor compound, the concentration of the acceptor compound in at least two of the two or more layers is different. In some embodiments, the concentration of the sensitizer compound in the layer including the sensitizer compound ranges from 1 to 50 wt%, 10 to 20 wt%, or 12 to 15 wt%. In some embodiments, the concentration of the acceptor compound in the layer including the acceptor compound ranges from 0.1 to 10 wt%, 0.5 to 5 wt%, or 1 to 3 wt%.

[0195] In some embodiments, the light-emitting region includes N layers, N>2. In some embodiments, a sensitizer compound is present in each of the N layers and an acceptor compound is included in the N-1 layer or less. In some embodiments, a sensitizer compound is present in each of the N layers and an acceptor compound is included in the N / 2 layer or less. In some embodiments, an acceptor compound is present in each of the N layers and a sensitizer compound is included in the N-1 layer or less. In some embodiments, an acceptor compound is present in each of the N layers and a sensitizer compound is included in the N / 2 layer or less.

[0196] In some embodiments, when a voltage is applied across the OLED, the OLED emits luminescent emission that includes an emission component from the S1 energy (first singlet energy) of the acceptor compound. In some embodiments, at least 65%, 75%, 85%, or 95% of the emission from the OLED has an intensity of at least 10 cd / m 2 In some embodiments, the S1 energy of the acceptor compound is lower than that of the sensitizer compound.

[0197] In some embodiments, the T1 energy (first triplet energy) of the host compound is higher than the T1 energies of the sensitizer compound and the acceptor compound, in some embodiments, the S1-T1 energy gap of the sensitizer compound and / or the acceptor compound is less than 400 meV, less than 300 meV, less than 250 meV, less than 200 meV, less than 150 meV, less than 100 meV, or less than 50 meV.

[0198] In some embodiments in which the sensitizer compound provides monochromatic sensitization (i.e., minimal energy loss upon energy transfer to the acceptor compound), the acceptor compound has a Stokes shift of 30 nm or less, 25 nm or less, 20 nm or less, 15 nm or less, or 10 nm or less. Examples include a broad blue phosphor that sensitizes a narrow blue-emitting acceptor.

[0199] In some embodiments in which the sensitizer compound provides a down-conversion process (e.g., using a blue emitter to sensitize a green emitter or using a green emitter to sensitize a red emitter), the acceptor compound has a Stokes shift of 30 nm or more, 40 nm or more, 60 nm or more, 80 nm or more, or 100 nm or more.

[0200] One way to quantify the qualitative relationship between a sensitizer compound (a compound used as a sensitizer in the emissive region of an OLED of the present disclosure) and an acceptor compound (a compound used as an acceptor in the emissive region of an OLED of the present disclosure) is to use the value Δλ=λ max1 -λ max2 where λ max1 and λ max2 is defined as follows: max1 is the emission maximum of the sensitizer compound at room temperature when the sensitizer compound is used as the only emitter in a first monochrome OLED (an OLED that emits only one color) with a first host. max2is the emission maximum of the acceptor compound at room temperature when the acceptor compound is used as the sole emitter in a second monochrome OLED having the same first host.

[0201] In some embodiments of the OLEDs of the present disclosure in which the sensitizer compound provides monochromatic sensitization (i.e., minimal energy loss upon energy transfer to the acceptor compound), Δλ (determined as described above) is less than or equal to a number selected from the group consisting of 15 nm, 12 nm, 10 nm, 8 nm, 6 nm, 4 nm, 2 nm, 0 nm, −2 nm, −4 nm, −6 nm, −8 nm, and −10 nm.

[0202] In some embodiments in which the emission of the acceptor is red-shifted by sensitization, Δλ is greater than or equal to a number selected from the group consisting of 20 nm, 30 nm, 40 nm, 60 nm, 80 nm, 100 nm.

[0203] In one embodiment, the sensitizer compound can function as a phosphorescent emitter in a room temperature OLED, and the sensitizer compound can be a metal coordination complex having a metal-carbon bond, a metal-nitrogen bond, or a metal-oxygen bond. In some embodiments, the metal is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Pd, Au, and Cu. In some embodiments, the metal is Ir. In some embodiments, the metal is Pt. In some embodiments, the sensitizer compound is a compound having ... coordination complex having a metal coordination complex having a metal coordination complex having a metal coordination complex having a metal coordination complex. A ) x (L B ) y (L C ) z having the formula: In the formula, L A , L B , and L C may be the same or different; x is 1, 2, or 3; y is 0, 1, or 2; z is 0, 1, or 2; x+y+z is the oxidation state of the metal; L A is the structure of the ligand list: [ka] [ka] is selected from the group consisting of Here, L B and L C are, independently, the following: [ka] and the structures of the Ligand List; T is selected from the group consisting of B, Al, Ga, and In; K 1’ is a direct bond or NR e , P.R. e , O, S, and Se; Each Y 1 ~Y 13 is independently selected from the group consisting of carbon and nitrogen; Y' is BR e , N.R. e , P.R. e , O, S, Se, C=O, S=O, SO2, CR e R f , SiR e R f , and GeR e R f’ selected from the group consisting of; R e and R f can be fused or linked to form a ring; Each R a , R b , R c , and R d independently represent a single substitution up to the maximum number of possible substitutions, or no substitution; Each R a1 , R b1 , R c1 , R d1 , R a , R b , R c , R d , R e , and Rf is independently hydrogen or a substituent selected from the group consisting of the general substituents defined herein; R a1 , R b1 , R c1 , R d1 , R a , R b , R c , and R d Any two of may be fused or linked to form a ring or to form a multidentate ligand.

[0204] In some embodiments, the formula M(L A ) x (L B ) y (L C ) z The metal therein is selected from the group consisting of Cu, Ag, or Au.

[0205] In some embodiments of the OLED, the sensitizer compound is Ir(L A )3, Ir(L A )(L B )2, Ir(L A )2(L B ), Ir(L A )2(L C ), Ir(L A )(L B )(L C ), and Pt(L A )(L B having a formula selected from the group consisting of: In the formula, L A , L B , and L C are different from each other in Ir compounds; In the formula, L A and L B may be the same or different in the Pt compound; In the formula, L A and L B may be combined to form a tetradentate ligand in Pt compounds.

[0206] In some embodiments of the OLED, the sensitizer compound is a compound in the following list of sensitizers: [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] selected from the group consisting of; Where: X 96 ~X 99 each is independently C or N; Each Y 100 is independently selected from the group consisting of NR″, O, S, and Se; L is independently selected from the group consisting of a direct bond, BR'', BR''R''', NR'', PR'', O, S, Se, C=O, C=S, C=Se, C=NR'', C=CR''R''', S=O, SO2, CR'', CR''R''', SiR''R'''', GeR''R'''', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; X in each case 100 is selected from the group consisting of O, S, Se, NR″, and CR″R′″; Each R 10a , R 20a , R 30a , R 40a , and R 50a , R A’’ , R B’’ , R C’’ , R D’’ , R E’’ , and R F’’ independently represent monosubstitution to maximal substitution or no substitution; R, R', R'', R''', R 10a , R 11a , R 12a , R 13a , R 20a , R 30a , R 40a , R 50a , R 60 , R 70 , R 97 , R 98 , R 99 , R A1’ , R A2’ , R A’’ , R B’’ , R C’’ , R D’’ , R E’’ , R F’’ , R G’’ , R H’’ , R I’’ , R J’’ , R K’’ , R L’’ , R M’’ , and R N’’Each of is independently hydrogen or a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

[0207] In some embodiments of the OLED in which the sensitizer is selected from the group consisting of the structures in the sensitizer list, R, R', R'', R''', R 10a , R 11a , R 12a , R 13a , R 20a , R 30a , R 40a , R 50a , R 60 , R 70 , R 97 , R 98 , R 99 , R A1’ , R A2’ , R A’’ , R B’’ , R C’’ , R D’’ , R E’’ , R F’’ , R G’’ , R H’’ , R I’’ , R J’’ , R K’’ , R L’’ , R M’’ , and R N’’ One or more of comprises a moiety selected from the group consisting of fully or partially deuterated aryl, fully or partially deuterated alkyl, boryl, silyl, germyl, 2,6-terphenyl, 2-biphenyl, 2-(tert-butyl)phenyl, tetraphenylene, tetrahydronaphthalene, and combinations thereof.

[0208] In some embodiments, the sensitizer and / or acceptor can be a phosphorescent or fluorescent emitter. Phosphorescence generally refers to the emission of photons accompanied by a change in electron spin. That is, the initial and final states of emission have different multiplicities, such as T1 to S0. Ir and Pt complexes, which are currently widely used in OLEDs, belong to phosphorescent emitters. In some embodiments, when exciplex formation involves triplet emitters, such exciplexes can also emit phosphorescence. On the other hand, fluorescent emitters generally refer to the emission of photons without a change in electron spin, such as S1 to S0. Fluorescent emitters can be delayed fluorescent emitters or non-delayed fluorescent emitters. Depending on the spin state, fluorescent emitters can be singlet or doublet emitters, or other multiplet emitters. It is believed that the internal quantum efficiency (IQE) of fluorescent OLEDs can exceed the 25% spin statistical limit due to delayed fluorescence. There are two types of delayed fluorescence, namely P-type and E-type delayed fluorescence. P-type delayed fluorescence arises from triplet-triplet annihilation (TTA). On the other hand, E-type delayed fluorescence does not depend on the collision of two triplets, but rather on the thermal population between the triplet state and the singlet excited state. Thermal energy can activate the transition from the triplet state back to the singlet state. This type of delayed fluorescence is also known as thermally activated delayed fluorescence (TADF). E-type delayed fluorescence properties can be found in exciplex systems or single compounds. Without being bound by theory, TADF has been shown to have a small singlet-triplet energy gap (ΔE S-T) is believed to require a compound or exciplex having a TADF-type TADF. There are two main types of TADF emitters, one called donor-acceptor type TADF and the other called multiple resonance (MR) type TADF. In many cases, a donor-acceptor single compound is constructed by connecting an electron donor moiety, such as an amino derivative or a carbazole derivative, with an electron acceptor moiety, such as an N-containing six-membered aromatic ring. A donor-acceptor exciplex can be formed between a hole transport compound and an electron transport compound. Examples of MR-TADF include highly conjugated boron-containing compounds. In some embodiments, the reverse intersystem crossing time from T1 to S1 of delayed fluorescence emission at 293 K is 10 microseconds or less. In some embodiments, such a time can be greater than 10 microseconds and less than 100 microseconds.

[0209] In some embodiments of the OLED, at least one of the following conditions applies: (1) The sensitizer compound can function as a TADF emitter in room temperature OLEDs; (2) The acceptor compound is a delayed fluorescent compound that functions as a TADF emitter in room temperature OLEDs.

[0210] In some embodiments of the OLED, the TADF emitter comprises at least one donor group and at least one acceptor group. In some embodiments, the TADF emitter is a metal complex. In some embodiments, the TADF emitter is a non-metal complex. In some embodiments, the TADF emitter is a Cu, Ag, or Au complex.

[0211] In some embodiments of the OLED, the TADF emitter is M(L 5 )(L 6 ) wherein M is Cu, Ag, or Au; and L 5 and L 6 is different, L 5 and L 6 are, independently, the following: [ka] [ka] is selected from the group consisting of Here, A 1 ~A 9 are each independently selected from C or N; Each R P , R Q , R U , R SA , R SB , R RA , R RB , R RC , R RD , R RE , and R RF is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof.

[0212] In some embodiments of the OLED, the TADF emitter has the following TADF list structure: [ka] [ka] is selected from the group consisting of:

[0213] In some embodiments of the OLED, the TADF emitter is [ka] [ka] and comprising at least one chemical moiety selected from the group consisting of: Here, Y T , Y U , Y V , and Y W are each independently selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO2, BRR′, CRR′, SiRR′, and GeRR′; Each R T may be the same or different, and each R T is independently a donor, an acceptor group, an organic linker bonded to a donor, an organic linker bonded to an acceptor group, or a terminal group selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, aryl, heteroaryl, and combinations thereof; R and R' are each independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof.

[0214] In some of the above embodiments, in each phenyl ring of any of the above structures, any carbon ring atom, together with their substituents, up to a total of three, can be substituted with N.

[0215] In some embodiments, the TADF emitter comprises at least one chemical moiety selected from the group consisting of nitriles, isonitriles, boranes, fluorides, pyridines, pyrimidines, pyrazines, triazines, aza-carbazoles, aza-dibenzothiophenes, aza-dibenzofurans, aza-dibenzoselenophenes, aza-triphenylenes, imidazoles, pyrazoles, oxazoles, thiazoles, isoxazoles, isothiazoles, triazoles, thiadiazoles, and oxadiazoles.

[0216] In some embodiments, the acceptor is a fluorescent compound that functions as an emitter in the OLED at room temperature. [ka] [ka] [ka] and comprising at least one chemical moiety selected from the group consisting of: Here, Y F , Y G , Y H , and Y I are each independently selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO2, BRR′, CRR′, SiRR′, and GeRR′; X F and X G are each independently selected from the group consisting of C and N; R F , R G , R, and R' are each independently hydrogen or a substituent selected from the group consisting of general substituents defined herein. In some of the above embodiments, in each phenyl ring of any of the above structures, any carbon ring atom, together with their substituents, up to a total of three, can be substituted with N.

[0217] In some embodiments of the OLED, the fluorescent compound is: [ka] [ka] [ka] [ka] is selected from the group consisting of Here, Y F1 ~Y F4 are each independently O, S, or NR F1 Selected from; R F1 and R 1S ~R 9S each independently represent a single substitution up to the maximum number of substitutions possible, or no substitution; R F1 and R 1S ~R 9S are each independently hydrogen or a substituent selected from the group consisting of general substituents defined herein.

[0218] In some embodiments, the acceptor compound has the structure of the following acceptor list: [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] is selected from the group consisting of:

[0219] In some of the above embodiments, in each phenyl ring of any of the above structures, any carbon ring atom, together with their substituents, up to a total of three, can be substituted with N.

[0220] In some embodiments, the acceptor compound comprises a fused ring system having at least 5-15 5-membered and / or 6-membered aromatic rings. In some embodiments, the acceptor compound comprises a first group and a second group, where the first group does not overlap with the second group; at least 80% of the singlet excited state population of the lowest singlet excited state is localized on the first group; and at least 80%, 85%, 90%, or 95% of the triplet excited state population of the lowest triplet excited state is localized on the second group.

[0221] In some embodiments, the light-emitting region further comprises a first host. In some embodiments, the sensitizer compound forms an exciplex with the first host in the OLED at room temperature. In some embodiments, in the light-emitting region, the first host has a LUMO energy lower than the LUMO energy of the sensitizer compound and the acceptor compound. In some embodiments, the first host has a HOMO energy lower than the HOMO energy of the sensitizer compound and the acceptor compound in the light-emitting region. In some embodiments, the first host has a HOMO energy higher than the HOMO energy of the sensitizer compound and the acceptor compound in the light-emitting region. In some embodiments, the first host has a HOMO energy higher than the HOMO energy of at least one of the sensitizer compound and the acceptor compound in the light-emitting region.

[0222] In some embodiments, the light-emitting region further comprises a second host. In some embodiments, the first host forms an exciplex with the second host in the OLED at room temperature. In some embodiments, the concentration of the first host and the second host in the layer or layers comprising the first host and the second host is greater than the concentration of the sensitizer compound and the acceptor compound in the layer or layers comprising the sensitizer compound and the acceptor compound. In some embodiments, the concentration of the first host and the second host in the layer or layers comprising the first host and the second host is greater than the concentration of the acceptor compound in the layer or layers comprising the sensitizer compound and the acceptor compound.

[0223] In some embodiments, the S1 energy of the first host is greater than the S1 energy of the acceptor compound. In some embodiments, the T1 energy of the first host is greater than the T1 energy of the sensitizer compound. In some embodiments, the sensitizer compound has a HOMO energy greater than the HOMO energy of the acceptor compound. In some embodiments, the second host has a HOMO level that is shallower than the HOMO level of the acceptor compound. In some embodiments, the HOMO level of the acceptor compound is deeper than at least one selected from the sensitizer compound and the first host.

[0224] In some embodiments, the first host and / or the second host may be selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ 2 -Benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, 5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, triazine, boryl, silyl, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ 2 -contains at least one chemical group selected from the group consisting of benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, and aza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene).

[0225] In some embodiments, each of the first host and / or the second host comprises one or more of the following: [ka] [ka] [ka] [ka] [ka] [ka] [ka] are independently selected from the group consisting of: Where: X 1 ~X 24 each is independently C or N; L' is a direct bond or an organic linker; Each Y A are independently selected from the group consisting of no bond, O, S, Se, CRR', SiRR', GeRR', NR, BR, and BRR'; R A’ , R B’ , R C’ , R D’ , R E’ , R F’ , and R G’ each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; R, R', R A’ , R B’ , R C’ , R D’ , R E’ , R F’ , and R G’ each is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, boryl, and combinations thereof; R A’ , R B’ , R C’ , R D’ , R E’ , R F’ , and R G’two adjacent ones of are optionally joined or fused to form a ring.

[0226] In yet another aspect, the OLED of the present disclosure can also include a light-emitting region comprising a blend of compounds disclosed in the present disclosure. In some embodiments, the light-emitting region is comprised of one or more organic layers, and at least one of the one or more organic layers has a minimum thickness selected from the group consisting of 350 Å, 400 Å, 450 Å, 500 Å, 550 Å, 600 Å, 650 Å, and 700 Å. In some embodiments, at least one of the one or more organic layers is formed from a light-emitting system having a figure of merit (FOM) value equal to or greater than a number selected from the group consisting of 2.50, 2.55, 2.60, 2.65, 2.70, 2.75, 2.80, 2.85, 2.90, 2.95, 3.00, 5.00, 10.0, 15.0, and 20.0. A definition of FOM is available in U.S. Patent Application Publication No. 2023 / 0292605, the entire contents of which are incorporated herein by reference. In some embodiments, at least one of the one or more organic layers comprises a compound or a combination thereof disclosed in Sections A and D of this disclosure.

[0227] In some embodiments, an OLED or light-emitting region comprising the inventive composition disclosed herein can be incorporated into a full-color pixel array of a device. The full-color pixel array of such a device comprises at least one pixel, and at least one pixel comprises a first subpixel and a second subpixel. The first subpixel comprises a first OLED comprising a first light-emitting region. The second subpixel comprises a second OLED comprising a second light-emitting region. In some embodiments, the first OLED and / or second OLED, the first light-emitting region and / or the second light-emitting region can be the same or different, and each can independently have various device characteristics and various embodiments of the inventive compounds contained therein, as well as various combinations and subcombinations of various device characteristics and various embodiments of the inventive compounds contained therein, as disclosed herein.

[0228] In some embodiments, the first light-emitting region has a peak wavelength, λ max1 and the second light-emitting region is configured to emit light having a peak wavelength λ max2 In some embodiments, the light emitting element is configured to emit light having a peak wavelength λ max1 and λ max2 The difference between the peak wavelengths λ and λ 2 is at least 4 nm, but within the same color range. For example, the light blue and dark blue light mentioned above. In some embodiments, the first light-emitting region has a peak wavelength λ 2 in one of the regions of the visible spectrum of 400 to 500 nm, 500 to 600 nm, or 600 to 700 nm. max1 and the second light-emitting region is configured to emit light having a peak wavelength λ in one of the remaining regions of the visible spectrum of 400-500 nm, 500-600 nm, or 600-700 nm. max2 In some embodiments, the first light-emitting region includes a first number of light-emitting layers deposited on top of one another in multiple cases, and the second light-emitting region includes a second number of light-emitting layers deposited on top of one another in multiple cases, the first number being different from the second number. In some embodiments, both the first light-emitting region and the second light-emitting region include phosphorescent materials, which may be the same or different. In some embodiments, the first light-emitting region includes phosphorescent materials, and the second light-emitting region includes fluorescent materials. In some embodiments, both the first light-emitting region and the second light-emitting region include fluorescent materials, which may be the same or different.

[0229] In some embodiments, at least one pixel of the OLED or light-emitting region includes a total of N subpixels; where the N subpixels include a first subpixel and a second subpixel; each of the N subpixels includes a light-emitting region; the total number of light-emitting regions in the at least one pixel is less than or equal to N-1. In some embodiments, the second light-emitting region is identical to the first light-emitting region, and each subpixel of the at least one pixel includes one light-emitting region that is identical to the first light-emitting region. In some embodiments, a full-color pixel array can have a plurality of pixels including a first pixel region and a second pixel region; where at least one display characteristic of the first pixel region is different from a corresponding display characteristic of the second pixel region, and the at least one display characteristic is selected from the group consisting of resolution, cavity mode, color, outcoupling, and color filter.

[0230] In some embodiments, the OLED is a stacked OLED including one or more charge generating layers (CGLs). In some embodiments, the OLED includes a first electrode, a first light-emitting region disposed on the first electrode, a first CGL disposed on the first light-emitting region, a second light-emitting region disposed on the first CGL, and a second electrode disposed on the second light-emitting region. In some embodiments, the first light-emitting region and / or the second light-emitting region can have various device characteristics as described above for pixelated devices. In some embodiments, the stacked OLED is configured to emit white light. In some embodiments, one or more of the light-emitting regions in a pixelated or stacked OLED include a sensitizer and an acceptor having various sensitizing device characteristics and various embodiments of the compounds of the present invention disclosed herein. For example, the first light-emitting region is included in the sensitizing device and the second light-emitting region is not included in the sensitizing device, and in some cases, both the first and second light-emitting regions are included in the sensitizing device.

[0231] In some embodiments, the OLED can emit at least 1%, 5%, 10%, 30%, 50%, 70%, 80%, 90%, 95%, 99% or 100% of light from the plasmonic mode. In some embodiments, at least one of the anode, cathode or a new layer disposed on the organic light-emitting layer functions as an enhancement layer. The enhancement layer includes a plasmonic material that non-radiatively couples to the emitter material and exhibits a surface plasmon resonance that transfers excited state energy from the emitter material to a non-radiative mode of surface plasmon polariton. In some embodiments, the enhancement layer is disposed within a threshold distance from the organic light-emitting layer, and the emitter material has a total non-radiative decay rate constant and a total radiative decay rate constant due to the presence of the enhancement layer. At the threshold distance, the total non-radiative decay rate constant is equal to the total radiative decay rate constant. Another threshold distance is the distance at which the total radioactive decay rate constant divided by the sum of the total non-radioactive decay rate constant and the total radioactive decay rate constant equals the photoluminescence yield of the luminescent material in the absence of the enhancement layer.

[0232] In order to reduce the amount of Dexter energy transfer between the sensitizer compound and the acceptor compound, it is preferred that the distance between the center of mass of the closest acceptor compound and the center of mass of the sensitizer compound in the emission region is large. Thus, in some embodiments, the distance between the center of mass of the acceptor compound and the center of mass of the sensitizer compound is at least 2 nm, 1.5 nm, 1.0 nm, or 0.75 nm.

[0233] Preferred acceptor / sensitizer VDR combinations (A): In some embodiments, it is preferred that the acceptor VDR is less than 0.33 to reduce the coupling of the transition dipole moment to the plasmon mode of the emitting acceptor compared to the isotropic emitter in order to achieve higher outcoupling efficiency. In some cases, when the acceptor VDR is less than 0.33, it is preferred that the sensitizer VDR is less than 0.33 in order to improve the outcoupling of the sensitizer and acceptor transition dipole moments and optimize the Forster energy transfer rate. Thus, in some embodiments of the invention OLED, the acceptor compounds in the invention OLED exhibit VDR values ​​of 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05 or less when the VDR is measured on an emissive thin film test sample having the acceptor compound as the only emitter; the sensitizer compounds in the invention OLED exhibit VDR values ​​of 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05 or less when the VDR is measured on an emissive thin film test sample having the sensitizer compound as the only emitter.

[0234] Preferred acceptor / sensitizer VDR combinations (B): In some embodiments, it is preferred that the VDR of the acceptor is less than 0.33 to reduce the coupling of the transition dipole moment to the plasmon mode of the emitting acceptor compared to the isotropic emitter in order to achieve higher outcoupling efficiency. In some cases, when the VDR of the acceptor is less than 0.33, it is preferred to minimize the intermolecular interactions between the sensitizer and the acceptor in order to reduce the degree of Dexter quenching. It may be preferred to have a sensitizer with a VDR greater than 0.33 by modifying the molecular structure of the sensitizer to reduce the intermolecular interactions. Thus, in some embodiments of the invention OLED, the acceptor compounds in the invention OLED exhibit VDR values ​​of less than or equal to 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05 when the VDR is measured on an emissive thin film test sample having the acceptor compound as the only emitter; the sensitizer compounds in the invention OLED exhibit VDR values ​​of greater than 0.33, 0.4, 0.5, 0.6, or 0.7 when the VDR is measured on an emissive thin film test sample having the sensitizer compound as the only emitter.

[0235] Preferred acceptor / sensitizer VDR combinations (C): In some embodiments, it is preferred that the VDR of the acceptor is greater than 0.33 to increase the coupling of the transition dipole moment to the plasmon mode of the acceptor compared to isotropic emitters in order to reduce the transient lifetime of excited states in the emissive layer. In some cases, the increased coupling to the plasmon mode can be paired with an enhancement layer in a plasmonic OLED device to improve efficiency and extend the operational lifetime. In some cases, when the VDR of the acceptor is greater than 0.33, it is preferred to minimize the intermolecular interactions between the sensitizer and the acceptor in order to reduce the degree of Dexter quenching. It may be preferred to have a sensitizer with a VDR less than 0.33 by modifying the molecular structure of the sensitizer to reduce the intermolecular interactions. Thus, in some embodiments of the invention OLED, when the VDR is measured on an emissive thin film test sample having the acceptor compound as the only emitter, the acceptor compound in the invention OLED exhibits a VDR value of greater than 0.33, 0.4, 0.5, 0.6, or 0.7; when the VDR is measured on an emissive thin film test sample having the sensitizer compound as the only emitter, the sensitizer compound in the invention OLED exhibits a VDR value of less than or equal to 0.33, 0.30, 0.25, 0.2, 0.15, 0.10, 0.08, or 0.05.

[0236] Preferred acceptor / sensitizer VDR combination (D): In some embodiments, the VDR of the acceptor is preferred to be greater than 0.33 in order to increase the coupling of the transition dipole moment of the acceptor to the plasmon mode, compared to isotropic emitters, in order to reduce the transient lifetime of excited states in the emissive layer. In some cases, the increased coupling to the plasmon mode can be paired with an enhancement layer in a plasmonic OLED device to improve efficiency and extend the operating lifetime. In some cases, when the VDR of the acceptor is greater than 0.33, the VDR of the sensitizer is preferred to be greater than 0.33 in order to improve the coupling of the transition dipole moment of the sensitizer and the acceptor to optimize the Forster energy transfer rate. Thus, in some embodiments of the invention OLED, when the VDR is measured on an emissive thin film test sample having the acceptor compound as the only emitter, the acceptor compound in the invention OLED exhibits a VDR value of greater than 0.33, 0.4, 0.5, 0.6, or 0.7; when the VDR is measured on an emissive thin film test sample having the sensitizer compound as the only emitter, the sensitizer compound in the invention OLED exhibits a VDR value of greater than 0.33, 0.4, 0.5, 0.6, or 0.7.

[0237] The VDR is the ensemble average fraction of vertically oriented molecular dipoles of the emissive compounds in a thin film sample of the emissive layer, where "vertical" is the orientation relative to the plane of the surface of the substrate on which the thin film sample is formed (i.e., normal to the surface of the substrate plane). A similar concept is the horizontal dipole ratio (HDR), which is the ensemble average fraction of horizontally oriented molecular dipoles of the emissive compounds in a thin film sample of the emissive layer, where the orientation "horizontal" is relative to the plane of the surface of the substrate on which the thin film sample is formed (i.e., parallel to the surface of the substrate plane). By definition, VDR+HDR=1. The VDR can be measured by angle-dependent measurements, polarization-dependent measurements, and photoluminescence measurements. The VDR of the emissive layer of a thin film test sample can be determined by comparing the measured emission pattern of a photoexcited thin film test sample to a computationally modeled pattern as a function of polarization. For example, modeled data for p-polarized emission is shown in Figure 3. Modeled p-polarized angular photoluminescence (PL) is plotted for emitters with different VDRs. A modeled PL peak is observed in the p-polarized PL around an angle of 45°, with the peak PL being larger when the emitter's VDR is high.

[0238] To measure the VDR value of a thin film test sample, a thin film test sample can be formed using an acceptor compound or a sensitizer compound (depending on whether the VDR of an acceptor compound or a sensitizer compound is being measured) as the only emitter in the thin film and a reference host compound A as the host. Preferably, the reference host compound A is [ka] The thin film test sample is formed by thermally evaporating the emitter compound and the host compound onto a substrate. For example, the emitter compound and the host compound can be co-evaporated. In some embodiments, the doping level of the emitter compound in the host can be 0.1% to 50% by weight. In some embodiments, the doping level of the emitter compound in the host can be 3% to 20% by weight for blue emitters. In some embodiments, the doping level of the emitter compound in the host can be 1% to 15% by weight for red and green emitters. The thickness of the thermally evaporated thin film test sample can have a thickness of 50 to 1000 Å.

[0239] In some embodiments, the OLED of the present disclosure can include a sensitizer, an acceptor, and one or more hosts in the emissive region, and the preferred acceptor / sensitizer VDR combinations (A)-(D) described above are still applicable. In these embodiments, the VDR value of the acceptor compound can be measured using a thin film test sample formed from one or more hosts and an acceptor, where the acceptor is the only emitter in the thin film test sample. Similarly, the VDR value of the sensitizer compound can be measured using a thin film test sample formed from one or more hosts and a sensitizer, where the sensitizer is the only emitter in the thin film test sample.

[0240] In this example used to generate Figure 3, a 30 nm thick film of material with refractive index 1.75 and emission is monitored in a semi-infinite medium with refractive index 1.75. Each curve is normalized to a photoluminescence intensity of 1 at an angle of 0° normal to the surface of the film. As the VDR of the emitter is changed, the peak near 45° increases significantly. When software is used to fit the VDR of the experimental data, the modeled VDR is changed until the difference between the modeled and experimental data is minimized.

[0241] Since the VDR indicates the average dipole coordination of the emissive compounds in a thin film sample, if there are additional compounds in the emissive layer capable of emitting light, but which do not contribute to the emission, the VDR measurement will not reflect the VDR. Also, the VDR of an emissive compound can be modified by including a host material that interacts with the emissive compound. Thus, an emissive compound in a thin film sample with host material A will show one VDR measurement, and the same emissive compound in a thin film sample with host material B will show a different VDR measurement. Furthermore, in some embodiments, exciplexes or excimers that form emissive states between two adjacent molecules are desirable. These emissive states can have a different VDR than if only one of the components of the exciplex or excimer was emitting or present in the sample.

[0242] In some embodiments, the OLED is a plasmonic OLED, hi some embodiments, the OLED is a wave-guided OLED.

[0243] In some embodiments, the light-emitting region can further include a second host. In some embodiments, the second host includes a moiety selected from the group consisting of bicarbazole, indolocarbazole, triazine, pyrimidine, pyridine, and boryl. In some embodiments, the second host has a HOMO level shallower than the HOMO level of the acceptor compound.

[0244] In some embodiments, the OLED emits white light at room temperature when a voltage is applied across the device.

[0245] In some embodiments, the OLED emits light at room temperature when a voltage is applied across the device; the emitting first radiative component has an emission λ independently selected from the group consisting of greater than 340 nm to less than or equal to 500 nm, greater than 500 nm to less than or equal to 600 nm, and greater than 600 nm to less than or equal to 900 nm. max1In some embodiments, the first emission component has a FWHM of 50 nm, 40 nm, 35 nm, 30 nm, 25 nm, 20 nm, 15 nm, 10 nm, or 5 nm or less. In some embodiments, the first emission component has a 10% onset of the emission peak that is less than 465 nm, 460 nm, 455 nm, or 450 nm.

[0246] In some embodiments, the sensitizer compound is partially or fully deuterated. In some embodiments, the acceptor compound is partially or fully deuterated. In some embodiments, the first host is partially or fully deuterated. In some embodiments, the second host is partially or fully deuterated.

[0247] In some embodiments, one of the first host and the second host is a hole transporting host and the other of the first host and the second host is an electron transporting host. In some embodiments, the first host is a hole transporting host and the first host is an amino, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, and 5λ 2 -benzo[d]benzo[4,5]imidazo[3,2-a]imidazole. In some embodiments, the first host is an electron transporting host, and the first host is selected from the group consisting of pyridine, pyrimidine, pyrazine, pyridazine, triazine, imidazole, aza-triphenylene, aza-carbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, 5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, boryl, aza-5λ 2 -contains at least one chemical group selected from the group consisting of benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, and aza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene).

[0248] In some embodiments, the OLED further comprises a color conversion layer or a color filter.

[0249] In some embodiments, the formulation may include at least two different compounds among the following compounds: a sensitizer compound, an acceptor compound, and a host.

[0250] In some embodiments, the chemical structure is selected from the group consisting of a monomer, a polymer, a macromolecule, and a supramolecule, and said chemical structure comprises at least two of the following components: a sensitizer compound, an acceptor compound, and a host.

[0251] In some embodiments, a premixed co-evaporation source is disclosed, which is a mixture including at least a first compound and a second compound; the co-evaporation source is a co-evaporation source for a vacuum deposition process or an OVJP process; the first compound and the second compound are differently selected from Group 1 consisting of a sensitizer compound, an acceptor compound, a first host compound, and a second host compound; the first compound has an evaporation temperature T1 between 150 and 350° C.; the second compound has an evaporation temperature T2 between 150 and 350° C.; the absolute value of T1-T2 is less than 20° C.; the first compound has a concentration C1 in the mixture and a concentration C2 in a test film, the test film being evaporated at a deposition rate of 2 Å / sec on a surface located at a predetermined distance away from the mixture to be evaporated, the deposition rate being 1×10 -6 Torr~1×10 -9 The mixture is formed by evaporating the mixture in a vacuum deposition tool at a constant pressure of 100 Torr; the absolute value of (C1-C2) / C1 is less than 5%. In some embodiments, the mixture includes a third compound; the third compound is different from the first compound and the second compound and is selected from the same group 1; the third compound has an evaporation temperature T3 between 150 and 350°C; the absolute value of T1-T3 is less than 20°C.

[0252] In some embodiments, the first compound has an evaporation temperature T1 between 200 and 350° C., and the second compound has an evaporation temperature between 200 and 350° C. In some embodiments, the absolute value of (C1-C2) / C1 is less than 3%. In some embodiments, the first compound has a vapor pressure of P1 at 1 atm, T1, and the second compound has a vapor pressure of P2 at 1 atm, T2; the ratio of P1 / P2 is in the range of 0.90:1 to 1.10:1. In some embodiments, the first compound has a first mass loss rate, and the second compound has a second mass loss rate, and the ratio of the first mass loss rate to the second mass loss rate is in the range of 0.90:1 to 1.10:1, 0.95:1 to 1.05:1, or 0.97:1 to 1.03:1. In some embodiments, the first compound and the second compound each have a purity of greater than 99% as measured by high pressure liquid chromatography. In some embodiments, the composition is in liquid form at a temperature lower than the lower temperature of T1 and T2.

[0253] In some embodiments, a method of making an organic light emitting device includes providing a substrate having a first electrode disposed thereon; -6 Torr~1×10 -9 depositing a first organic layer on the first electrode by evaporating a premixed co-evaporation source of the mixture of the first and second compounds in a high vacuum deposition tool at a chamber base pressure of Torr; and depositing a second electrode on the first organic layer.

[0254] It should be understood that all compound and device embodiments described herein may be interchangeable where those embodiments are applicable to different aspects of the overall disclosure.

[0255] In some embodiments, each of the first compound, second compound, sensitizer compound, acceptor compound, and host compound described herein can be at least 10% deuterated, at least 20% deuterated, at least 30% deuterated, at least 40% deuterated, at least 50% deuterated, at least 60% deuterated, at least 70% deuterated, at least 80% deuterated, at least 90% deuterated, at least 95% deuterated, at least 99% deuterated, or 100% deuterated. As used herein, percentage of deuteration has its usual meaning and includes the percentage of hydrogen atoms (e.g., positions that are hydrogen or deuterium) that can be replaced with deuterium atoms.

[0256] C. Other Aspects of OLEDs of the Present Disclosure In some embodiments, the OLED can further include an additional host, the additional host including a triphenylene including a benzo-fused thiophene or a benzo-fused furan, and any substituent in the host can independently be selected from the group consisting of C n H 2n+1 , O.C. n H 2n+1 , OAr1, N(C n H 2n+1 )2, N(Ar1)(Ar2), CH=CH-C n H 2n+1 , C≡CC n H 2n+1 , Ar1, Ar1-Ar2, C n H 2n -Ar1 is a non-fused substituent selected from the group consisting of, or is unsubstituted, n is an integer from 1 to 10, and Ar1 and Ar2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof.

[0257] In some embodiments, the additional host comprises at least one chemical group selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, 5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, triazine, boryl, silyl, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, and aza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene).

[0258] In some embodiments, the additional host is: [ka] [ka] and combinations thereof.

[0259] In some embodiments, the additional host comprises a metal complex.

[0260] In yet another embodiment, the OLED of the present disclosure can also include a light-emitting region that includes a formulation disclosed in the Compounds section of this disclosure.

[0261] In some embodiments, at least one of the anode, cathode, or a new layer disposed on the organic light-emitting layer functions as an enhancement layer. The enhancement layer includes a plasmonic material that non-radiatively couples to the emitter material and exhibits a surface plasmon resonance that transfers excited state energy from the emitter material to a non-radiative mode of surface plasmon polaritons. The enhancement layer is disposed within a threshold distance from the organic light-emitting layer, and the emitter material has a total non-radiative decay rate constant and a total radiative decay rate constant due to the presence of the enhancement layer, and at the threshold distance, the total non-radiative decay rate constant is equal to the total radiative decay rate constant. In some embodiments, the OLED further includes an outcoupling layer. In some embodiments, the outcoupling layer is disposed on the enhancement layer opposite the organic light-emitting layer. In some embodiments, the outcoupling layer is disposed on the opposite side of the light-emitting layer from the enhancement layer, but still outcouples energy from the surface plasmon mode of the enhancement layer. The outcoupling layer scatters energy from the surface plasmon polaritons. In some embodiments, this energy is scattered into free space as photons. In other embodiments, the energy is scattered from the surface plasmon mode into other modes of the device, such as, but not limited to, an organic waveguide mode, a substrate mode, or another waveguide mode. If the energy is scattered into a non-free space mode of the OLED, other outcoupling schemes can be incorporated to extract the energy into free space. In some embodiments, one or more intervening layers can be disposed between the enhancement layer and the outcoupling layer. Examples of intervening layers can be dielectric materials, including organic, inorganic, perovskite, oxides, and can include stacks and / or mixtures of these materials.

[0262] The enhancement layers modify the effective properties of the medium in which the emitter material resides, resulting in any or all of the following: reduced emission rate, altered emission line shape, change in emission intensity with angle, change in stability of the emitter material, change in efficiency of the OLED, and reduced efficiency roll-off of the OLED device. Placing an enhancement layer on the cathode side, anode side, or both results in an OLED device that utilizes any of the above effects. In addition to the specific functional layers shown in the various OLED examples described and illustrated herein, OLEDs according to the present disclosure can include any of the other functional layers frequently found in OLEDs.

[0263] The enhancement layer can be comprised of a plasmonic material, an optically active metamaterial, or a hyperbolic metamaterial. As used herein, a plasmonic material is a material whose real part of the permittivity crosses zero in the visible or ultraviolet region of the electromagnetic spectrum. In some embodiments, the plasmonic material comprises at least one metal. In such embodiments, the metal can comprise at least one of Ag, Al, Au, Ir, Pt, Ni, Cu, W, Ta, Fe, Cr, Mg, Ga, Rh, Ti, Ru, Pd, In, Bi, Ca, alloys or mixtures of these materials, and stacks of these materials. In general, a metamaterial is a medium composed of different materials such that the medium as a whole behaves differently than the sum of its material parts. In particular, an optically active metamaterial is defined as a material that has both a negative permittivity and a negative permeability. On the other hand, a hyperbolic metamaterial is an anisotropic medium in which the permittivity or permeability has different signs for different spatial directions. Optically active and hyperbolic metamaterials are distinct from many other photonic structures, such as distributed Bragg reflectors ("DBRs"), in that they are media that appear uniform in the direction of propagation on the length scale of the wavelength of light. Using terminology understood by those skilled in the art, the dielectric constant of a metamaterial in the direction of propagation can be described by an effective medium approximation. Plasmonic and metamaterials provide a way to control the propagation of light and can enhance OLED performance in a variety of ways.

[0264] In some embodiments, the enhancement layer is provided as a planar layer. In other embodiments, the enhancement layer has periodically, quasi-periodically, or randomly arranged wavelength-sized features, or periodically, quasi-periodically, or randomly arranged sub-wavelength-sized features. In some embodiments, the wavelength-sized features and the sub-wavelength-sized features have sharp edges.

[0265] In some embodiments, the outcoupling layer has periodically, quasi-periodically, or randomly arranged wavelength-sized features or periodically, quasi-periodically, or randomly arranged sub-wavelength-sized features. In some embodiments, the outcoupling layer can be composed of nanoparticles, and in other embodiments, the outcoupling layer is composed of nanoparticles arranged on a material. In these embodiments, the outcoupling can be tunable by at least one of changing the size of the nanoparticles, changing the shape of the nanoparticles, changing the material of the nanoparticles, adjusting the thickness of the material, changing the refractive index of the material or the refractive index of a further layer disposed on the nanoparticles, changing the thickness of an enhancement layer, and / or changing the material of the enhancement layer. The nanoparticles of the device can be formed from at least one of a metal, a dielectric material, a semiconductor material, an alloy of a metal, a mixture of a dielectric material, a stack or layer of one or more materials, and / or a core of one type of material coated with a shell of another type of material. In some embodiments, the outcoupling layer is composed of at least metal nanoparticles, the metal being selected from the group consisting of Ag, Al, Au, Ir, Pt, Ni, Cu, W, Ta, Fe, Cr, Mg, Ga, Rh, Ti, Ru, Pd, In, Bi, Ca, alloys or mixtures of these materials, and stacks of these materials. The nanoparticles can have further layers disposed on them. In some embodiments, the polarization of the emitted light can be adjusted using the outcoupling layer. By varying the dimensions and periodicity of the outcoupling layer, the type of polarization that is preferentially outcoupled to air can be selected. In some embodiments, the outcoupling layer also serves as an electrode of the device.

[0266] In yet another aspect, the present disclosure also provides a consumer product comprising the OLED of the present disclosure.

[0267] In some embodiments, the consumer product includes an OLED having an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer can include a composition described herein.

[0268] In some embodiments, the consumer product can be one of a flat panel display, a computer monitor, a medical monitor, a television, a billboard, a light for indoor or outdoor illumination and / or signaling, a head-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a mobile phone, a tablet, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a microdisplay less than 2 inches diagonal, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video wall including multiple displays aligned together, a theater or stadium screen, a light therapy device, and a signage.

[0269] In general, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons migrate to the oppositely charged electrode, respectively. When an electron and hole localize on the same molecule, an "exciton" is formed, which is a localized electron-hole pair having an excited energy state. Light is emitted via a photoemissive mechanism when the exciton relaxes. In some cases, the exciton may be localized on an excimer or exciplex. Non-radiative mechanisms such as thermal relaxation may also occur, but are generally considered undesirable.

[0270] Some OLED materials and configurations are described in US Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated by reference in their entireties.

[0271] Early OLEDs used emissive molecules that emitted light from their singlet state ("fluorescence"), as disclosed, for example, in U.S. Patent No. 4,769,292, which is incorporated by reference in its entirety. Fluorescence emission typically occurs on a time frame of less than 10 nanoseconds.

[0272] More recently, OLEDs have been demonstrated that have emissive materials that emit light from triplet states ("phosphorescence"). Baldo et al., "Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices," Nature, Vol. 395, No. 151-154, 1998; ("Baldo-I") and Baldo et al., "Very high-efficiency green organic light-emitting devices based on electrophosphorescence," Appl. Phys. Lett., Vol. 75, No. 3, 4-6 (1999) ("Baldo-II"), which are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704, columns 5-6, which are incorporated by reference.

[0273] FIG. 1 illustrates an organic light-emitting device 100. The figures are not necessarily drawn to scale. Device 100 may include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, a cathode 160, and a barrier layer 170. Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164. Device 100 may be fabricated by depositing the layers described, in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704, columns 6-10, which are incorporated by reference.

[0274] Further examples are available for each of these layers. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Patent No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F4-TCNQ in a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003 / 0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Patent No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li in a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003 / 0230980, which is incorporated by reference in its entirety. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entirety, disclose examples of cathodes including composite cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, conductive, sputter-deposited ITO layer. The theory and use of blocking layers are described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003 / 0230980, which are incorporated by reference in their entirety. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004 / 0174116, which is incorporated by reference in its entirety. A description of protective layers can be found in U.S. Patent Application Publication No. 2004 / 0174116, which is incorporated by reference in its entirety.

[0275] FIG. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. Device 200 may be fabricated by depositing the layers described, in order. Because the most common OLED configuration has the cathode disposed above the anode, and device 200 has cathode 215 disposed below anode 230, device 200 may be referred to as an "inverted" OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200. FIG. 2 provides an example of how some layers may be omitted from the structure of device 100.

[0276] The simple layer structures illustrated in Figures 1 and 2 are provided as non-limiting examples, and it is understood that the embodiments of the present disclosure may be used in conjunction with a wide variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. A functional OLED may be achieved by combining the various layers described in various ways, or layers may be omitted entirely based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. While many of the examples provided herein describe the various layers as including a single material, it is understood that combinations of materials, such as mixtures of hosts and dopants, or more generally mixtures, may be used. Layers may also have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an "organic layer" disposed between a cathode and an anode. The organic layer may include a single layer, or may further include multiple layers of different organic materials, such as those described with respect to Figures 1 and 2.

[0277] Structures and materials not specifically described may be used, such as OLEDs (PLEDs) composed of polymeric materials such as those disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. As a further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example, as described in U.S. Pat. No. 5,707,745 to Forrest et al., which is incorporated by reference in its entirety. OLED structures may deviate from the simple layered structures illustrated in FIGS. 1 and 2. For example, the substrate may include angled reflective surfaces to improve outcoupling, such as the mesa structures described in U.S. Pat. No. 6,091,195 to Forrest et al. and / or the recessed structures described in U.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated by reference in their entirety.

[0278] Devices fabricated according to embodiments of the present disclosure may further include a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment, including moisture, vapors and / or gases, etc. The barrier layer may be deposited on, under or next to the substrate, the electrodes, or on any other portion of the device, including the edges. The barrier layer may include a single layer or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase and compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate inorganic or organic compounds or both. Preferred barrier layers include mixtures of polymeric and non-polymeric materials, as described in U.S. Pat. No. 7,968,146, PCT Patent Application Nos. PCT / US2007 / 023098 and PCT / US2009 / 042829, which are incorporated herein by reference in their entireties. To be considered a "mixture", the polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and / or simultaneously. The weight ratio of polymeric to non-polymeric materials can be in the range of 95:5 to 5:95. The polymeric and non-polymeric materials can be made from the same precursor materials. In one example, the mixture of polymeric and non-polymeric materials consists essentially of polymeric silicon and inorganic silicon.

[0279] Devices made according to embodiments of the present disclosure can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into various electrical products or intermediate components. Such electrical products or intermediate components include display screens, lighting devices (such as discrete light source devices or lighting panels) that can be utilized by end-user product manufacturers. Such electronic component modules can optionally include driving electronics and / or power sources. Devices made according to embodiments of the present disclosure can be incorporated into a wide variety of consumer products having one or more electronic component modules (or units) incorporated therein. Disclosed are consumer products that include OLEDs that include compounds of the present disclosure in the organic layer of the OLED. Such consumer products include any type of product that includes one or more light sources and / or one or more visual displays of some kind. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, lights for indoor or outdoor illumination and / or signaling, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, mobile phones, tablets, phablets, personal digital assistants (PDAs), wearable devices, laptop computers, digital cameras, camcorders, viewfinders, microdisplays (displays less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls including multiple displays aligned together, theater or stadium screens, phototherapy devices, and signage. A variety of control mechanisms, including passive matrix and active matrix, can be used to control devices made according to the present disclosure. Many of the devices are intended for use within a temperature range that is comfortable for humans, such as 18°C ​​to 30°C, and more preferably room temperature (20-25°C), but may also be used outside this temperature range, for example, at temperatures between -40°C and +80°C Celsius.

[0280] Further details regarding OLEDs and the above definitions can be found in US Pat. No. 7,279,704, which is incorporated by reference in its entirety.

[0281] The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may use the materials and structures. More generally, organic devices such as organic transistors may use the materials and structures.

[0282] In some embodiments, the OLED has one or more properties selected from the group consisting of flexible, rollable, foldable, stretchable, and bendable. In some embodiments, the OLED is transparent or semi-transparent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.

[0283] In some embodiments, the OLED further comprises a layer comprising a delayed fluorescent emitter. In some embodiments, the OLED comprises an RGB pixel array or a white and color filter pixel array. In some embodiments, the OLED is a mobile device, a handheld device, or a wearable device. In some embodiments, the OLED is a display panel having a diagonal of less than 10 inches or an area of ​​less than 50 square inches. In some embodiments, the OLED is a display panel having a diagonal of at least 10 inches or an area of ​​at least 50 square inches. In some embodiments, the OLED is a lighting panel.

[0284] In some embodiments, the first compound may be an emissive dopant. In some embodiments, the first compound may generate luminescence via phosphorescence, fluorescence, thermally activated delayed fluorescence, or TADF (also called E-type delayed fluorescence; see, for example, U.S. Application No. 15 / 700,352, which is incorporated herein by reference in its entirety), triplet-triplet annihilation, or a combination of these processes. In some embodiments, the emissive dopant may be a racemic mixture or may be enriched in one enantiomer. In some embodiments, the first compound may be homoleptic (each ligand is the same). In some embodiments, the first compound may be heteroleptic (at least one ligand is different from the others). When there are multiple ligands coordinated to the metal, in some embodiments, the ligands may all be the same. In some other embodiments, at least one ligand is different from the other ligands. In some embodiments, all of the ligands may be different from each other. This is true even in embodiments where a ligand coordinated to a metal can be linked to other ligands coordinated to the metal to form a tridentate, tetradentate, pentadentate, or hexadentate ligand. Thus, when the coordinating ligands are linked together, in some embodiments, all of the ligands can be the same, and in some other embodiments, at least one of the linked ligands can be different from the others.

[0285] In some embodiments, the first compound can be used as a phosphorescent sensitizer in an OLED, where one or more layers of the OLED contain an acceptor in the form of one or more fluorescent and / or delayed fluorescent emitters. In some embodiments, the first compound can be used as one component of an exciplex used as a sensitizer. As a phosphorescent sensitizer, the first compound must be capable of energy transfer to an acceptor, which either releases the energy or further transfers the energy to a final emitter. The acceptor concentration can range from 0.001% to 100%. The acceptor can be either in the same layer as the phosphorescent sensitizer, or in one or more different layers. In some embodiments, the acceptor is a TADF emitter. In some embodiments, the acceptor is a fluorescent emitter. In some embodiments, the emission can come from any or all of the sensitizer, the acceptor, and the final emitter.

[0286] According to another aspect, compositions including two or more of the sensitizer, host, second host, acceptor, etc. compounds described herein are also disclosed.

[0287] The OLEDs disclosed herein can be incorporated into one or more of a consumer product, an electronic component module, and a lighting panel. The organic layer can be an emissive layer, and in some embodiments, the compound can be an emissive dopant, and in other embodiments, the compound can be a non-emissive dopant.

[0288] In yet another aspect of the present disclosure, a composition is described that includes the novel compounds disclosed herein. The composition may include one or more components selected from the group consisting of a solvent, a host, a hole injection material, a hole transport material, an electron blocking material, a hole blocking material, and an electron transport material disclosed herein.

[0289] The present disclosure encompasses any chemical structure that includes the novel compounds of the present disclosure, or monovalent or polyvalent variants thereof. In other words, the inventive compounds, or monovalent or polyvalent variants thereof, can be part of a larger chemical structure. Such chemical structures can be selected from the group consisting of monomers, polymers, macromolecules, and supramolecules (also known as supermolecules). As used herein, a "monovalent variant of a compound" refers to a moiety that is identical to the compound, except that one hydrogen has been removed and replaced with a bond to the remainder of the chemical structure. As used herein, a "polyvalent variant of a compound" refers to a moiety that is identical to the compound, except that more than one hydrogen has been removed and replaced with a bond to the remainder of the chemical structure. In the example of a supramolecule, the inventive compounds can also be incorporated into the supramolecular complex without a covalent bond.

[0290] F. Combinations of Compounds of the Present Disclosure with Other Materials The materials described herein as useful for a particular layer in an organic light-emitting device can be used in combination with a wide variety of other materials present in the device.For example, the emissive dopants disclosed herein can be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes, and other layers that may be present.The materials described or referenced below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and those skilled in the art can easily consult the literature to identify other materials that may be useful in combination.

[0291] a) Conductive dopants: The charge transport layer is doped with a conductive dopant, which significantly changes the density of charge carriers and therefore its conductivity. The conductivity can be increased by generating charge carriers in the matrix material and, depending on the type of dopant, a change in the Fermi level of the semiconductor can also be achieved. The hole transport layer can be doped with a p-type conductive dopant and an n-type conductive dopant is used in the electron transport layer. In some embodiments, the conductive dopant comprises at least one chemical moiety selected from the group consisting of cyano, fluorinated aryl or heteroaryl, fluorinated alkyl or cycloalkyl, alkylene, heteroaryl, amide, benzodithiophene, and highly conjugated heteroaryl groups extended by acyclic double bonds.

[0292] b) HIL / HTL: The hole injection / transport material used in the present disclosure is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injection / transport material. Examples of materials include phthalocyanine or porphyrin derivatives; aromatic amine derivatives; indolocarbazole derivatives; polymers containing fluorocarbons; polymers with conductive dopants; conductive polymers such as PEDOT / PSS; self-assembly monomers derived from compounds such as phosphonic acid and silane derivatives; MoO x p-type semiconducting organic compounds such as 1,4,5,8,9,12-hexaazatriphenylene hexacarbonitrile; metal complexes, and crosslinkable compounds, but are not limited to these.

[0293] Examples of aromatic amine derivatives used in HIL or HTL include those having the following general structure: [ka] These include, but are not limited to:

[0294] Ar 1 From Ar 9each of the above is a group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridyl indole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazole, and aromatic heterocyclic compounds such as sulphurazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and aromatic hydrocarbon ring groups and aromatic heterocyclic groups, which may be the same or different groups and which are bonded to each other directly or via at least one of an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, a phosphorus atom, a boron atom, a chain structural unit, and an aliphatic ring group. 1 From Ar 9 Each of may be unsubstituted or substituted with common substituents as described above, and any two substituents may be joined or fused to form a ring.

[0295] In some embodiments, each Ar 1 From Ar 9 are, independently, the following: [ka] (wherein k is an integer from 1 to 20; X 101From X 108 is C or N; Z 101 is C, N, O, or S.

[0296] Examples of metal complexes used in the HIL or HTL include those of the general formula: [ka] (wherein Met is a metal that may have an atomic weight greater than 40; (Y 101 -Y 102 ) is a bidentate ligand, and Y 101 and Y 102 are independently selected from C, N, O, P and S; 101 is another ligand; k' is an integer value from 1 to the maximum number of ligands that can be bound to the metal; and k'+k'' is the maximum number of ligands that can be bound to the metal.

[0297] In some embodiments, (Y 101 -Y 102 ) is a 2-phenylpyridine or 2-phenylimidazole derivative. In some embodiments, (Y 101 -Y 102 In some embodiments, Met is selected from Ir, Pt, Pd, Os, Cu, and Zn. In some embodiments, the metal complex is + For the / Fc couple, it has a minimum oxidation potential of less than about 0.6 V in solution.

[0298] In some embodiments, the HIL / HTL materials include phthalocyanine and porphyrin compounds, starburst triarylamines, CF xThe conductive polymers are selected from the group consisting of fluorohydrocarbon polymers, conductive polymers (e.g., PEDOT:PSS, polyaniline, polythiophene), phosphonic acid and threan SAMs, triarylamine or polythiophene polymers with conductive dopants, organic compounds with conductive inorganic compounds (such as molybdenum and tungsten oxides), n-type semiconducting organic complexes, metal organometallic complexes, crosslinkable compounds, polythiophene-based polymers and copolymers, triarylamines, triarylamines with spirofluorene cores, arylamine carbazole compounds, triarylamines with (di)benzothiophene / (di)benzofuran, indolocarbazoles, isoindole compounds, and metal carbene complexes.

[0299] c) EBL: An electron blocking layer (EBL) can be used to reduce the number of electrons and / or excitons that leave the emissive layer. The presence of such a blocking layer in a device can result in significantly higher efficiency and / or longer lifetime compared to a similar device lacking a blocking layer. A blocking layer can also be used to confine emission to a desired region of an OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and / or a higher triplet energy than one or more emitters closest to the EBL interface. In some embodiments, the compound used in the EBL comprises at least one carbazole group and / or at least one arylamine group. In some embodiments, the HOMO level of the compound used in the EBL is shallower than the HOMO level of one or more hosts in the EML. In some embodiments, the compound used in the EBL comprises the same molecule or the same functional group as used as one of the hosts described herein.

[0300] d) Additional hosts: The light-emitting layer of the organic EL device of the present disclosure preferably includes at least a light-emitting material as a dopant and a host material. Examples of the host material are not particularly limited, and any metal complex or organic compound can be used as long as the host does not completely quench the emission of the dopant. In some embodiments, the light-emitting layer can include two hosts, a first host and a second host. In some embodiments, the first host is a hole-transporting host, and the second host is an electron-transporting host. In some embodiments, the first host is a hole-transporting host, and the second host is a bipolar host. In some embodiments, the first host is an electron-transporting host, and the second host is a bipolar host. In some embodiments, the first host and the second host can form an exciplex. In some embodiments, the light-emitting layer can include a third host. In some embodiments, the third host is selected from the group consisting of an insulating host (wide band gap host), a hole-transporting host, and an electron-transporting host. In some embodiments, the third host forms an exciplex with either the first host and the second host, or with both the first host and the second host. In some embodiments, the emissive layer can include a fourth host. In some embodiments, the fourth host is selected from the group consisting of insulating hosts (wide band gap hosts), hole transporting hosts, and electron transporting hosts. In some embodiments, the fourth host forms an exciplex with one of the first host, the second host, and the third host, with two of the first host, the second host, and the third host, or with each of the first host, the second host, and the third host. In some embodiments, the electron transporting host has a LUMO of less than -2.4 eV, less than -2.5 eV, less than -2.6 eV, or less than -2.7 eV. In some embodiments, the hole transporting host has a HOMO greater than -5.6 eV, greater than -5.5 eV, greater than -5.4 eV, or greater than -5.35 eV. The HOMO and LUMO values ​​can be determined using solution electrochemistry.Solution cyclic voltammetry and differential pulse voltammetry can be performed using a CH Instruments model 6201B potentiostat with anhydrous dimethylformamide (DMF) solvent and tetrabutylammonium hexafluorophosphate as the supporting electrolyte. Glassy carbon, platinum wire, and silver wire were used as the working, counter, and reference electrodes, respectively. The electrochemical potential can be referenced to the internal ferrocene-ferroconium redox couple (Fc / Fc+) by measuring the peak potential difference from differential pulse voltammetry. The corresponding highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) energies can be determined by reference to the redox potentials of the cations and anions relative to ferrocene (4.8 eV vs. vacuum) according to the literature ((a) Fink, R.; Heischkel, Y.; Thelakkat, M.; Schmidt, H.-W. Chem. Mater. 1998, 10, 3620-3625; (b) Pommerehne, J.; Vestweber, H.; Guss, W.; Mahrt, RF; Bassler, H.; Porsch, M.; Daub, J. Adv. Mater. 1995, 7, 551).

[0301] In some embodiments, the compounds of the invention described herein can be used as one such host, and the compounds described below can be used as one or more other such hosts.

[0302] Examples of metal complexes that may be used as the one or more other hosts include those having the general formula: [ka] (wherein Met is a metal; Y 103 -Y 104 ) is a bidentate ligand, and Y 103 and Y 104 are independently selected from C, N, O, P and S; 101is another ligand; k' is an integer value from 1 to the maximum number of ligands that can be bound to the metal; and k'+k'' is the maximum number of ligands that can be bound to the metal.

[0303] In some embodiments, the metal complex is [ka] where (ON) is a bidentate ligand with the metal coordinated to atoms O and N.

[0304] In some embodiments, Met is selected from Ir and Pt. 103 -Y 104 ) is a carbene ligand.

[0305] In some embodiments, the one or more other hosts are selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridyl indole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole , quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-carbazole, aza-indolocarbazole, aza-triphenylene, aza-tetraphenylene, 5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, 5,9 and aromatic heterocyclic compounds such as 1,2,3,4,5-dioxa-13b-boranaphtho[3,2,1-de]anthracene; and aromatic hydrocarbon ring groups and aromatic heterocyclic groups, which may be the same or different, and which are bonded to each other directly or via at least one of an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, a phosphorus atom, a boron atom, a chain structural unit, and an aliphatic ring group. Each option within each group may be unsubstituted or substituted by the general substituents described herein, or may be further fused.

[0306] In some embodiments, the one or more other hosts include: [ka] [ka] (In the formula, k is an integer of 0 to 20 or 1 to 20. X 101 ~X 108 is independently selected from C or N. 101 and Z 102 is independently selected from C, N, O, or S.

[0307] In some embodiments, the one or more other hosts are selected from the group consisting of aryl carbazoles, metal 8-hydroxyquinolates (e.g., alq3, balq), metal phenoxybenzothiazole compounds, conjugated oligomers and polymers (e.g., polyfluorenes), aromatic fused rings, zinc complexes, chrysene-based compounds, aryl triphenylene compounds, poly-fused heteroaryl compounds, donor-acceptor type molecules, dibenzofuran / dibenzothiophene compounds, polymers (e.g., pvk), spirofluorene compounds, spirofluorene-carbazole compounds, indomethacin compounds, tetrahydrofuran ... The carbazoles are selected from the group consisting of arylcarbazoles, five-membered electron deficient heterocycles (e.g., triazoles, oxadiazoles), tetraphenylene complexes, metal phenoxypyridine compounds, metal coordination complexes (e.g., Zn, Al with N^N ligands), dibenzothiophene / dibenzofuran-carbazole compounds, silicon / germanium aryl compounds, aryl benzoyl esters, carbazoles linked by non-conjugated groups, aza-carbazole / dibenzofuran / dibenzothiophene compounds, and high triplet metal organometallic complexes (e.g., metal-carbene complexes).

[0308] In some embodiments, the one or more other hosts are triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ 2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, 5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, azaborinine, oxaborinine, dihydroacridine, xanthene, dihydrobenzoazasiline, dibenzoxasiline, phenoxazine, phenoxathiin, phenothiazine, dihydrophenazine, fluorene, naphthalene, anthracene, phenanthrene, phenanthroline, benzoquinoline, quinoline, isoquinoline, quinazoline, pyrimidine, pyrazine, pyridine, triazine, boryl, silyl, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ 2 -contains at least one chemical group selected from the group consisting of benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, and aza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene).

[0309] In some embodiments, one or more of the other hosts have the following structure for Host Group 1: [ka] [ka] [ka] [ka] [ka] [ka] may be selected from the group consisting of Where: Each of J1 to J6 is independently C or N; L' is a direct bond or an organic linker; Each Y AA , Y BB, Y CC , and Y DD are independently selected from the group consisting of no bond, a direct bond, O, S, Se, CRR', SiRR', GeRR', NR, BR, and BRR'; R A’ , R B’ , R C’ , R D’ , R E’ , R F’ , and R G’ each independently represents from a single substitution to maximal substitution or no substitution; Each R, R', R A’ , R B’ , R C’ , R D’ , R E’ , R F’ , and R G’ are independently hydrogen or a substituent selected from the group consisting of general substituents defined herein; any two substituents may be joined or fused to form a ring; When possible, each unsubstituted aromatic carbon atom is optionally substituted with N to form an aza-substituted ring.

[0310] In some embodiments, at least one of J1-J3 is N, in some embodiments, at least two of J1-J3 are N, and in some embodiments, all three of J1-J3 are N. In some embodiments, each Y CC and Y DD is preferably O, S, and SiRR', and more preferably O or S. In some embodiments, at least one unsubstituted aromatic carbon atom is substituted with N to form an azacycle.

[0311] In some embodiments, the host is selected from the group consisting of EG1-MG1-EG1 through EG53-MG27-MG53, which have the formula EGa-MGb-EGc, or, when MGb is absent, EG1-EG1 through EG53-EG53, which have the formula EGa-EGc, where a is an integer from 1 to 53, b is an integer from 1 to 27, and c is an integer from 1 to 53. The structures of EG1 through EG53 are shown below: [ka] [ka] The structures of MG1 to MG27 are shown below: [ka] In the MGb structure above, the two binding positions in the asymmetric structures MG10, MG11, MG12, MG13, MG14, MG17, MG24 and MG25 are labelled with numbers for identification.

[0312] In some embodiments, the host can be any of their aza-substituted variants, their fully or partially deuterated variants, and combinations thereof. In some embodiments, the host has the formula EGa-MGb-Egc and is selected from the group consisting of h1 through h112 defined in the Host Group 2 List below, where MGb, EGa, and EGc are each defined as follows: [ka] [ka] In the above table, the EGa and EGc structures that are bound to one of the asymmetric structures MG10, MG11, MG12, MG13, MG14, MG17, MG24, and MG25 are indicated with a numeric prefix that identifies their binding position in the MGb structure.

[0313] e) Emitter materials in the EML: One or more emitter materials can be used with the compounds or devices of the present disclosure. The emitter materials can be emissive or non-emissive in the current device as described herein. Examples of emitter materials are not particularly limited, and any compound can be used as long as the compound can generate emission in a typical OLED device. Examples of suitable emitter materials include, but are not limited to, compounds that can generate emission via phosphorescence, non-delayed fluorescence, delayed fluorescence, especially thermally activated delayed fluorescence, i.e., TADF (also called E-type delayed fluorescence), triplet-triplet annihilation, or a combination of these processes.

[0314] f)HBL: A hole blocking layer (HBL) can be used to reduce the number of holes and / or excitons that leave the emissive layer. The presence of such a blocking layer in a device can result in significantly higher efficiency and / or longer lifetime compared to a similar device lacking a blocking layer. Blocking layers can also be used to confine emission to desired regions of an OLED. In some embodiments, the HBL material has a lower HOMO (further away from the vacuum level) and / or higher triplet energy than one or more emitters closest to the HBL interface.

[0315] In some embodiments, the compounds used in the HBL contain the same molecules or the same functional groups as those used as the hosts described above.

[0316] In some embodiments, the compound used in HBL is [ka] (In the formula, k is an integer of 1 to 20; L 101 is another ligand, and k' is an integer from 1 to 3.

[0317] g)ETL: The electron transport layer (ETL) may include a material capable of transporting electrons. The electron transport layer may be intrinsic (undoped) or doped. Doping may be used to increase electrical conductivity. Examples of ETL materials are not particularly limited, and any metal complex or organic compound may be used as long as it is typically used to transport electrons.

[0318] In some embodiments, the compounds used in the ETL have the following moieties in the molecule: [ka] and fullerene, where k is an integer from 1 to 20; 101 ~X 108 is selected from C or N; Z 101 is selected from the group consisting of C, N, O, and S.

[0319] In some embodiments, the metal complex used in the ETL has the following general formula: [ka] (Wherein, (ON) or (NN) is a bidentate ligand having a metal coordinated to the atoms O, N or N,N; L 101 is another ligand; and k' is an integer value from 1 to the maximum number of ligands that can be bound to the metal.

[0320] In some embodiments, the ETL material is selected from the group consisting of anthracene-benzimidazole compounds, azatriphenylene derivatives, anthracene-benzothiazole compounds, metal 8-hydroxyquinolates, metal hydroxybenzoquinolates, bathocuprine compounds, 5-membered electron deficient heterocycles (e.g., triazoles, oxadiazoles, imidazoles, benzimidazoles), silole compounds, arylborane compounds, fluorinated aromatic compounds, fullerenes (e.g., C60), triazine complexes, and Zn(N^N) complexes.

[0321] h) Charge Generation Layer (CGL) In tandem or stacked OLEDs, the CGL plays an important role in performance and consists of n-doped and p-doped layers for injecting electrons and holes, respectively. The electrons and holes are supplied from the CGL and the electrodes. The electrons and holes consumed in the CGL are replenished by the electrons and holes injected from the cathode and anode, respectively; then the bipolar current gradually reaches a steady state. Typical CGL materials contain n- and p-conducting dopants used in the transport layers.

[0322] In any of the compounds disclosed herein, hydrogen atoms may be partially or fully deuterated. The minimum amount of hydrogen in a compound that is deuterated is selected from the group consisting of 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 99% and 100%. As used herein, percent deuteration has its usual meaning and includes the percent of all possible hydrogen and deuterium atoms that are replaced by deuterium atoms. In some embodiments, the deuterium atom is bonded to an aromatic ring. In some embodiments, the deuterium atom is bonded to a saturated carbon atom, such as an alkyl or cycloalkyl carbon atom. In some other embodiments, the deuterium atom is bonded to a heteroatom, such as a Si or Ge atom.

[0323] It is understood that the various embodiments described herein are merely examples and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein can be substituted with other materials and structures without departing from the spirit of the invention. Thus, the invention as claimed may include variations from the specific examples and preferred embodiments described herein, as would be apparent to one of ordinary skill in the art. It is understood that the various theories as to why the invention works are not intended to be limiting.

[0324] It should also be understood that all compound and device embodiments described herein may be interchangeable where those embodiments are also applicable under different aspects of the overall disclosure.

[0325] E. Experimental Section The OLEDs were fabricated on glass substrates precoated with an indium tin oxide (ITO) layer with a sheet resistance of 15 Ω / sq. Prior to the deposition or coating of the organic layers, the substrates were degreased with solvent and then treated with oxygen plasma at 100 mTorr and 50 W for 1.5 min and UV ozone for 5 min.

[0326] The device in Table 1 was thermally evaporated in high vacuum (<10 -7 The devices were fabricated at 3700 Å (1000 Å) pressure in a nitrogen glove box (<1 ppm H2O and O2). The anode electrode was 750 Å of indium tin oxide (ITO). The example device had organic layers consisting of, from the ITO surface, 100 Å of compound 1 (HIL), 250 Å of compound 2 (HTL), 50 Å of HH1 (EBL), 300 Å of HH1 doped with a percentage of EH1 or EH2 and a percentage of BD1 or BD2 (EML), 50 Å of EH1 or EH2 (BL), 300 Å of compound 3 doped with 35% compound 4 (ETL), 10 Å of compound 3 (EIL) followed by 1,000 Å of Al (cathode). All devices were encapsulated with a glass lid sealed with epoxy resin in a nitrogen glove box (<1 ppm H2O and O2) immediately after fabrication, and a moisture getter was incorporated into the package. Doping percentages are in volume percent. [ka] [ka] Table 1: Characteristics of the inventive device and comparative devices. The device lifetime was measured at 20 mA / cm 2 The measurements were performed under the above aging conditions, and normalized to Comparative Device 1 for HS1 and to Comparative Device 3 for HS2. [Table 2]

[0327] As shown in Table 1, OLED devices containing HS1 show longer lifetimes with BD1 compared to BD2. BD1 has more bulkiness around the pyridine compared to BD2. This supports the contention that the lifetime of devices utilizing OBO as an E-host can be increased by adding bulky groups around reactive sites on the emitter. Furthermore, OLED devices containing HS2 do not show longer lifetimes with BD1 compared to BD2. This supports the hypothesis that the effect of bulky groups on lifetime is specific to OBO with E-host EH2. These improvements are beyond any values ​​attributable to experimental error and the improvements observed were significant.

Claims

1. an anode; A cathode; a light-emitting layer disposed between the anode and the cathode; 1. An organic light emitting device (OLED) comprising: the light-emitting layer comprises a first compound and a second compound; The first compound has the structure of Formula I: 【Chemistry 1】 having During the ceremony, each of moieties A, B, C and D is independently a monocyclic ring or a polycyclic fused ring system, and each ring of the monocyclic ring or polycyclic fused ring system is independently a 5- or 6-membered, carbocyclic or heterocyclic ring; X 1 ~X 5 each is independently C or N; K 1 , K 2 , and K 3 Each of R α ), P(R α ), B(R α ), C(R α ) (R β ) and Si(R α ) (R β ) selected from the group consisting of; m and n are each independently 0 or 1; m+n=1 or 2; The second compound has the structure of Formula II: 【Chemistry 2】 having During the ceremony, Z 1 ~Z 11 each is independently C or N; x and y are each independently 0 or 1; the LUMO energy of the second compound is −2.33 eV or less; During the ceremony, L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 each independently represents a direct bond or BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO 2 , CR, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; R A , R B , R C , R D , R E , R F , and R G each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; R α , R β , R, R', R'', R''', R A , R B , R C , R D , R E , R F , and R G each is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and Any two substituents may be linked or fused to form a ring; at least one of the following conditions (1) to (4) is true: (1) At least one R D The substituent is not hydrogen; (2) one of moieties A, B, C, or D of formula I contains a pyridine moiety coordinated to Pt, the pyridine moiety having a center of mass C1; the nearest calculated intermolecular distance at 0 K between C1 and the boron atom of formula II is 3.57 Å or greater; (3) R of formula II E , R G , or R F At least one of has a sphericity of 0.04 or greater and a LUMO energy of formula II is −2.33 eV or less; (4) Moiety A is benzimidazole, moieties B and C are each phenyl, moiety D is pyridine, and X 1 If N, then at least one of the following two conditions is true: (a) at least one R that is not hydrogen D the total molecular weight of all of the substituents is ≧57 g / mol; or (b) Two R D the substituents are joined together to form a ring; An organic light emitting device (OLED) comprising:

2. each of moieties A, B, C, and D is independently selected from benzene, pyridine, pyrimidine, pyridazine, pyrazine, triazine, imidazole, imidazole derived carbene, pyrazole, pyrrole, oxazole, furan, thiophene, thiazole, triazole, naphthalene, quinoline, isoquinoline, quinazoline, benzofuran, aza-benzofuran, benzoxazole, aza-benzoxazole, benzothiophene, aza-benzothiophene, benzothiazole, aza-benzothiazole, benzoselenophene, aza-benzoselenophene, 2. The OLED of claim 1, wherein the OLED is selected from the group consisting of benzene, indene, aza-indene, indole, aza-indole, benzimidazole, aza-benzimidazole, benzimidazole derived carbene, aza-benzimidazole derived carbene, carbazole, aza-carbazole, dibenzofuran, aza-dibenzofuran, dibenzothiophene, aza-dibenzothiophene, quinoxaline, phthalazine, phenanthrene, aza-phenanthrene, anthracene, aza-anthracene, phenanthridine, fluorene, and aza-fluorene.

3. At least one R D but, 【Chemistry 3】 【Chemistry 4】 【Chemistry 5】 having a structure selected from the group consisting of: During the ceremony, Each Y aa and Y bb are independently a direct bond, BR, BRR', NR, PR, O, S, Se, C=O, C=S, C=Se, C=NR, C=CRR', S=O, SO 2 , CR, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; Q A , Q B , Q C , Q D , and Q E each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; Each R, R', Q A , Q B , Q C , Q D , Q E , Q A1 , Q B1 , Q C1 , Q D1 , and Q E1 is independently hydrogen or a substituent selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and Any two substituents may be joined or fused to form a ring; 10. The OLED of claim 1 .

4. The first compound is 【Chemistry 6】 【Chemistry 7】 【Chemistry 8】 【Chemistry 9】 【Chemistry 10】 【Chemistry 11】 【Chemistry 12】 having a structure selected from the group consisting of: During the ceremony, X 6 ~X 9 each is independently C or N; K is a direct bond, O, S, N(R α ), P(R α ), B(R α ), C(R α ) (R β ), and Si(R α ) (R β ) selected from the group consisting of; L is a direct bond, or BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO 2 , CR, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; Y A and Y B each independently represents BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO 2 , CR, CRR′, SiRR′, GeRR′; R AA , R BB , R CC , and R DD each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; Each R, R', R'', R''', R α , R β , R X , R Y , R A1 , R D1 , R G1 , R G2 , R G3 , R G4 , R G5 , R G6 , R G7 , R G8 , R AA , R BB , R CC , and R DD is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and 10. The OLED of claim 1, wherein any two substituents can be linked or fused to form a ring.

5. The first compound is 【Chemistry 13】 【Chemistry 14】 【Chemistry 15】 【Chemistry 16】 【Chemistry 17】 【Chemistry 18】 having a structure selected from the group consisting of: During the ceremony, K is a direct bond, O, S, N(R α ), P(R α ), B(R α ), C(R α ) (R β ), and Si(R α ) (R β ) selected from the group consisting of; L is a direct bond, or BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO 2 , CR, CRR', SiRR', GeRR', alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; Y A and Y B each independently represents BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CR''R''', S=O, SO 2 , CR, CRR′, SiRR′, GeRR′; R AA , R BB , R CC , and R DD each independently represents from a single substitution up to the maximum allowed substitution, or no substitution; Each R, R', R'', R''', R α , R β , R X , R Y , R A1 , R D1 , R G1 , R G2 , R G3 , R G4 , R G5 , R G6 , R G7 , R G8 , R AA , R BB , R CC , and R DD is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and Any two substituents may be joined or fused to form a ring; 10. The OLED of claim 1 .

6. The first compound is 【Chemistry 19】 【Chemistry 20】 【Chemistry 21】 【Chemical 22】 【Chemistry 23】 10. The OLED of claim 1 having a structure selected from the group consisting of:

7. the second compound is a host; and / or The OLED of claim 1 , wherein the second compound is an E-host.

8. Z 1 ~Z 11 each of is C; and / or L 5 is selected from the group consisting of O, S, and Se; and / or L 6 is selected from the group consisting of O, S, and Se; and / or x+y=2; and / or At least one R E , R F , or R G comprises a moiety selected from the group consisting of aryl, heteroaryl, silyl, amino, combinations thereof, and partially and fully deuterated variants thereof; and / or R of Formula II E , R G , or R F at least one of has a sphericity of 0.04 or greater; and / or R E , R F Or R G At least one of the following structures: 【Chemistry 24】 【Chemistry 25】 (In the formula, Z 1 ~Z 202 are each independently C or N; Each Y A1 are BR, BRR', NR, PR, O, S, Se, C=O, C=S, C=Se, C=NR, C=CRR', S=O, SO 2 , CR, CRR′, SiRR′, and GeRR′; Each R W independently represent a single substitution up to the maximum allowed substitution, or no substitution; Each R, R′, and R W is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and Any two R W can be linked or fused to form a ring; 10. The OLED of claim 1 .

9. The second compound is 【Chemistry 26】 is selected from the group consisting of During the ceremony, Z 30 , Z 31 , and Z 32 each is independently C or N; Each Y A is independently selected from the group consisting of BR, BRR', NR, PR, P(O)R, O, S, Se, C=O, C=S, C=Se, C=NR', C=CRR, S=O, SO2, CRR', SiRR', and GeRR'; R EE , R FF , R GG , R JJ , R KK , and R LL each independently represents from a single substitution to maximal substitution, or no substitution; R, R', R EE , R FF , R GG , R JJ , R KK , and R LL each is independently hydrogen or a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, germyl, selenyl, and combinations thereof; and Any two adjacent substituents may be joined or fused to form a ring.

10. The OLED of claim 1 .

10. 13. A consumer product comprising the OLED of claim 1.